成人甲状腺功能异常与代谢综合征关系的流行病学研究
|
摘要
目的调查宁波市某石油化工企业全体在职和退休员工甲状腺功能异常的患病现况。方法采用普查方法,调查了该企业10461名员工的甲状腺疾病史和甲状腺功能状况。结果在该石化员工人群中,各种甲状腺功能异常的总患病率为4.62%,标化患病率2.95%；男性和女性的患病率分别2.70%和9.11%,标化患病率相应为2.06%和5.31%。该人群对甲状腺疾病的知晓率为1.81%,男性0.86%,女性4.09%；已知晓有甲状腺疾病史者中,高达25%的人甲状腺功能依然未能正常。否认有甲状腺疾病史者中,甲状腺功能异常的患病率为2.87%,男性1.88%,女性5.29%。亚临床甲状腺功能减退症占新发现甲状腺功能异常者的81.7%,70岁以上老年人患病率高于其它年龄段者。结论宁波市某石化企业员工甲状腺功能异常患病率超过4.5%,以亚临床甲状腺功能减退症最为多见,患病率随年龄增长而升高,女性患病率高于男性。
目的调查宁波市某石油化工企业全体老年退休员工甲状腺功能异常的患病现况。方法采用普查方法,调查了该企业1759名60岁以上退休员工的甲状腺疾病史和甲状腺功能状况。
结果在该老年人群中,已知甲状腺疾病的患病率为3.9%,女性7.6%,男性1.9%；否认有甲状腺疾病史者中,甲状腺功能异常的患病率为4.7%,女性6.9%,男性3.5%；该老年人群已知与新发现甲状腺功能异常的总患病率达8.5%,女性14.0%,男性5.4%。亚临床甲状腺功能减退症占新发现甲状腺功能异常者的81.0%。老年人甲状腺功能异常患病率显著高于非老年人。结论宁波市老年石化退休员工甲状腺功能异常患病率高达8.5%,以亚临床甲状腺功能减退症最为多见,女性患病率高于男性。
目的探讨和分析宁波市某石化企业员工代谢综合征的患病率及其分布特点。方法采用普查方法,调查了该企业10461名20-90岁男女员工的完整资料。代谢综合征诊断标准采用国际糖尿病联盟2005年关于代谢综合征的诊断标准(IDF共识标准)。结果①该企业员工中心性肥胖、血压升高或高血压、血糖升高或糖尿病、低高密度脂蛋白胆固醇(HDL-C)血症、高甘油三酯(TG)血症和代谢综合征的患病率分别为21.2%、43.5%、11.1%、12.1%、27.1%和10.2%。②按2000年全国人口构成标化,代谢综合征的标化患病率为5.8%,男性患病率与标化患病率分别为10.1%和5.9%,女性患病率与标化患病率分别为10.5%和5.7%。③上述代谢异常患病率随年龄增长而升高,其中40岁以上人群血糖升高或糖尿病、血压升高或高血压及代谢综合征的患病率为40岁以下人群的2-9倍。结论该石化企业员工具有较高的代谢综合征及其相关疾病的患病率。
目的探讨甲状腺功能异常与代谢综合征及其各组分的关系。方法调查10461名年龄20-90岁的宁波市某石油化工企业员工人群,测定其体重指数、腰围、血压、空腹血糖和血脂谱。采用2005年国际糖尿病联盟(IDF)标准诊断代谢综合征。结果①该企业员工甲状腺功能异常和代谢综合征的患病率分别为4.6%和10.2%；②有近1／5员工存在腰围超标并含至少一项代谢异常；③TSH降低、正常和升高三组间代谢综合征的患病率未见有显著差异；④代谢综合征5项组分中,经logistic回归分析显示,低HDL-C与TSH减低有关(OR=2.808,95%CI：1.632-4.833),高TG与TSH升高有关(OR=1.483,95%CI：1.128-1.950)；⑤进一步分析TSH水平与血脂谱的关系,男性仅TC和HDL-C随TSH减低而降低；女性除Apo(A1)外,TC、LDL-C、TG、Apo(B)随TSH升高而逐渐升高,HDL-C在TSH异常组都呈显著降低。结论甲状腺功能异常与代谢综合征之间未见有明显相关性。甲状腺功能对于代谢综合征各组分的影响,主要表现为血脂谱改变,故对甲状腺功能异常者,有必要进行血脂检测。
目的探讨甲状腺功能异常与高尿酸血症的关系。方法调查10461名20-90岁宁波市某石化企业员工人群,询问甲状腺疾病的手术、药物治疗史,检测血促甲状腺素(TSH)、游离甲状腺素(FT4)、游离三碘甲腺原氨酸(FT3)和血尿酸(SUA)。结果①该人群中高尿酸血症总患病率18.9%,男性23.6%,女性7.7%。②甲状腺疾病总体知晓率1.8%,男性0.8%,女性4.1%。③10272名否认甲状腺疾病史者中,甲状腺功能异常总患病率2.9%,男性患病率1.9%,其中TSH降低者0.3%,TSH升高者1.6%；女性患病率5.3%,其中TSH降低者0.8%,TSH升高者4.5%。④与TSH正常组相比,女性TSH升高组和降低组的血尿酸均显著升高(P<0.001)。⑤TSH升高是高尿酸血症的独立影响因素(OR值男性为1.93、女性为1.97,P<0.001)。结论高尿酸血症患病率与TSH升高独立相关,临床或亚临床甲状腺功能减退症可能是高尿酸血症的危险因素。
目的探讨亚临床甲状腺功能减退症对血管内皮功能的影响。方法对70例30-55岁经健康体检无显著心血管疾病或甲状腺手术史者(其中35例甲状腺功能正常对照者,35例TSH 4.7-9.9mU／L的亚临床甲状腺功能减退症者),应用高分辨率超声显像法检测其肱动脉血管内皮依赖性舒张功能。结果两组的肱动脉内径基础值(分别为3.82±0.25mm和3.83±0.25mm)及含服硝酸甘油后肱动脉内径变化百分率(分别为17.8%±5.5%和17.3%±5.4%),均无显著性差异,亚临床甲状腺功能减退症组反应性充血后肱动脉内径变化的百分率(16.0%±4.5%)较正常对照组(16.4%±6.7%)也无显著降低(P>0.05)。结论轻中度亚临床甲状腺功能减退症患者不存在血管内皮功能障碍,TSH升高本身可能不是心血管病的直接危险因素。
Objective To estimate the prevalence of thyroid dysfunction among the staff of a Petrochemical Corporation in Ningbo. Methods A population survey was conducted.10461 workers (including retired workers) were enrolled. Their medical history were investigated by questionairys,and blood samples were collected for thyroid function detection. Results In this petrochemical employees cohort, the prevalences of thyroid dysfunctions were 4.62%,2.70% and 9.11% in total population, male and female, repectively, while the standardized rates were 2.95%,2.06% and 5.31%, accordingly. The prevalence of diagnosed thyroid diseases was 1.81%,0.86% in male and 4.09% in female. Twenty-five percent of individuals with thyroid surgery or medications had abnormal thyroid function. The prevalence of unrecognized thyroid dysfunctions was 2.87%,1.88% in male and 5.29% in female. Subclinical hypothyroidism accounted for 81.7% of unrecognized thyroid dysfunctions.The prevalence of subclincical hypothyroidism was higher in aged people over 70 yrs than in other ages. Conclusions The prevalence of thyroid dysfunctions was over 4.5% in all workers of a Petrochemical Corporation in Ningbo. Subclinical hypothyroidism was the most popular form in all kinds of unrecognized thyroid functional disorders. The prevalence of subclinical hypothyroidism increased with age and was higher in female than in male.
Objective To estimate the prevalence of thyroid dysfunctions among the retired staff of a Petrochemical Corporation in Ningbo. Methods A population survey was conducted.1759 retired workers over age 60 years were investigated to participate in a health survey with a questionnaire, and blood samples were collected for thyroid function detection. Results In this elderly cohort, the prevalence of diagnosed thyroid diseases was 3.9%,7.6% in female and 1.9% in male. The prevalence of unrecognized thyroid dysfunctions was 4.7%,6.9% in female and 3.5% in male. The prevalence of total thyroid dysfunctions was 8.5%,14.0% in female and 5.4% in male. Subclinical hypothyroidism accounted for 81.0% of unrecognized thyroid dysfunctions. The prevalence of thyroid dysfunction was higher in elderly people than in non-elderly persons.
Conclusions The prevalence of thyroid dysfunctions was over 10% in the elderly retired workers of a Petrochemical Corporation in Ningbo. Subclinical hypothyroidism was the most popular form in all kinds of unrecognized thyroid functional disorders. The prevalence of subclinical hypothyroidism was higher in females than in males.
Objective To explore the prevalence of metabolic syndrome in an occupational population.
Methods The data of totally 10461 employees aged 20-90 collected from a Petrochemical Corporation in Ningbo were analyzed. The prevalence of metabolic syndrome was calculated using the criteria of IDF definition pulished in 2005. Results①The prevalence of central overweight, blood pressure over 130/85 mmHg or hypertension, impaired fasting glucose or diabetes mellitus, low HDL-C, high TG and metabolic syndrome were 21.2%、43.5%、11.1%、12.1%、27.1% and 10.2%.②The standardized prevalence of metabolic syndrome was 5.8%. The prevalence of metabolic syndrome was 10.1% in male and 10.5% in female, while the standardized rates were 5.9% and 5.7%, accordingly.③The prevalence of these diseases were increased with aging, and compared with the people yonger than 40 years old, the prevalence of hyperglucemia, hyertention and metabolic syndrome were 2-9 times higher in the people older than 40. Conclusion High prevalence of metabolic syndrome and its related diseases among the employees were observed in the Petrochemical Corporation in Ningbo.
Objective To study the relationship between the prevalence of thyroid dysfunction and components of metabolic syndrome in Ningbo. Methods A total of 10461 workers aged 20 to 90 years of a Petrochemical Corporation in Ningbo were included. Body mass index (BMI), waist circumference, blood pressure, fasting plasma glucose and lipid profile concentrations were measured in all subjects. Metabolic syndrome was diagnosed according to the International Diabetes Federation (IDF) criteria. Results①The prevalences of metabolic syndrome and overall thyroid dysfunction were 10.2% and 4.6%, respectively.②About one fifth of petrochemical employees had abdominal obesity with at least one component of metabolic syndrome.③There was no significant difference in the prevalence of metabolic syndrome within lowered TSH, normal TSH and elevated TSH groups.④Logistic regression analyses revealed that low HDL-C was associated with lowered TSH (OR=2.808,95%CI:1.632-4.833), and high TG was associated with elevated TSH (OR=1.483,95%CI:1.128-1.950).⑤There were significant correlations between serum TSH levels and lipid parameters such as TC in males, TG and LDL-C in females, and HDL-C in both gender. Conclusion The prevalence of thyroid dysfunction was not associated with central obesity, hypertension and hyperglycemia. Lipid disorder was correlation with serum TSH levels.
Objective To study the relationship between the prevalence of hyperuicemia and thyroid dysfunction. Methods 10461 active and retired workers aged 20 to 90 years of a Petrochemical Corporation in Ningbo were included. Serum thyroid-stimulatin hormone (TSH), free thyroxine (FT4), free triiodothyronine (FT3) and serum uric acid (SUA) were measured. Results①The prevalence of hyperuricemia was 18.9% in total workers,23.6% in males and 7.7% in females, respectively.②The prevalence of former diagnosed thyroid diseases was 1.8% in total,0.8% in males and 4.1% in females, respectively.③In 10272 individuals without a history of thyroid disease, the prevalence of thyroid dysfunction was 2.9% in total,1.9%in males and 5.3% in females, respectively. The percentage of subjects with a low TSH concentration was 0.3% in males and 0.8% in females; the percentage of subjects with an elevated TSH concentration was 1.6% in males and 4.5% in females.④Compared with normal TSH workers, the serum uric acid was significantly increased in subjects with either high TSH or low TSH (P<0.001) in females.⑤Logistic regression analysis revealed that low TSH was an independent factor associated with hyperuricemia (OR=1.93 for males and 1.97 for females, P all<0.001, respectively). Conclusion The prevalence of hyperuricemia was independently associated with increased TSH concentration. Overt or subclinical hypothyroidism may be risk factors for hyperuricemia.
Objective To study the effect of mild subclinical hypothyroidism on the endothelium-dependent relaxing function in middle-aged persons. Methods Seventy participants in middle-aged persons without cardiovascular disease and thyroid surgry history were included in this study. Thirty-five of them with normal thyroid function and the others with little-mild subclinical hypothyroidism (TSH 4.7-9.9 mU/L). Endothelial-dependent relaxing function was measured with high-resolution B-mode ultrasound in all participants. Results Flow-mediated dilatation was not significantly impaired in the group of mild subclinical hypothyroidism compared with matched controls with normal thyoid function (16.0%±4.5% vs 16.4%±6.7%, P>0.05). There were no significant difference in baseline (3.82±0.25 mm vs 3.83±0.25 mm) and the nitroglycerin-induced dilatation (17.8%±5.5% vs 17.3%±5.4%) in two groups. Conclusion Endothelium-dependent relaxing function was not impaired in middle-aged patients with mild subclinical hypothyroidism, and mild increased TSH levels may not as a direct risk factor of cardiovascular disease.
目的调查宁波市某石油化工企业全体老年退休员工甲状腺功能异常的患病现况。方法采用普查方法,调查了该企业1759名60岁以上退休员工的甲状腺疾病史和甲状腺功能状况。
结果在该老年人群中,已知甲状腺疾病的患病率为3.9%,女性7.6%,男性1.9%；否认有甲状腺疾病史者中,甲状腺功能异常的患病率为4.7%,女性6.9%,男性3.5%；该老年人群已知与新发现甲状腺功能异常的总患病率达8.5%,女性14.0%,男性5.4%。亚临床甲状腺功能减退症占新发现甲状腺功能异常者的81.0%。老年人甲状腺功能异常患病率显著高于非老年人。结论宁波市老年石化退休员工甲状腺功能异常患病率高达8.5%,以亚临床甲状腺功能减退症最为多见,女性患病率高于男性。
目的探讨和分析宁波市某石化企业员工代谢综合征的患病率及其分布特点。方法采用普查方法,调查了该企业10461名20-90岁男女员工的完整资料。代谢综合征诊断标准采用国际糖尿病联盟2005年关于代谢综合征的诊断标准(IDF共识标准)。结果①该企业员工中心性肥胖、血压升高或高血压、血糖升高或糖尿病、低高密度脂蛋白胆固醇(HDL-C)血症、高甘油三酯(TG)血症和代谢综合征的患病率分别为21.2%、43.5%、11.1%、12.1%、27.1%和10.2%。②按2000年全国人口构成标化,代谢综合征的标化患病率为5.8%,男性患病率与标化患病率分别为10.1%和5.9%,女性患病率与标化患病率分别为10.5%和5.7%。③上述代谢异常患病率随年龄增长而升高,其中40岁以上人群血糖升高或糖尿病、血压升高或高血压及代谢综合征的患病率为40岁以下人群的2-9倍。结论该石化企业员工具有较高的代谢综合征及其相关疾病的患病率。
目的探讨甲状腺功能异常与代谢综合征及其各组分的关系。方法调查10461名年龄20-90岁的宁波市某石油化工企业员工人群,测定其体重指数、腰围、血压、空腹血糖和血脂谱。采用2005年国际糖尿病联盟(IDF)标准诊断代谢综合征。结果①该企业员工甲状腺功能异常和代谢综合征的患病率分别为4.6%和10.2%；②有近1／5员工存在腰围超标并含至少一项代谢异常；③TSH降低、正常和升高三组间代谢综合征的患病率未见有显著差异；④代谢综合征5项组分中,经logistic回归分析显示,低HDL-C与TSH减低有关(OR=2.808,95%CI：1.632-4.833),高TG与TSH升高有关(OR=1.483,95%CI：1.128-1.950)；⑤进一步分析TSH水平与血脂谱的关系,男性仅TC和HDL-C随TSH减低而降低；女性除Apo(A1)外,TC、LDL-C、TG、Apo(B)随TSH升高而逐渐升高,HDL-C在TSH异常组都呈显著降低。结论甲状腺功能异常与代谢综合征之间未见有明显相关性。甲状腺功能对于代谢综合征各组分的影响,主要表现为血脂谱改变,故对甲状腺功能异常者,有必要进行血脂检测。
目的探讨甲状腺功能异常与高尿酸血症的关系。方法调查10461名20-90岁宁波市某石化企业员工人群,询问甲状腺疾病的手术、药物治疗史,检测血促甲状腺素(TSH)、游离甲状腺素(FT4)、游离三碘甲腺原氨酸(FT3)和血尿酸(SUA)。结果①该人群中高尿酸血症总患病率18.9%,男性23.6%,女性7.7%。②甲状腺疾病总体知晓率1.8%,男性0.8%,女性4.1%。③10272名否认甲状腺疾病史者中,甲状腺功能异常总患病率2.9%,男性患病率1.9%,其中TSH降低者0.3%,TSH升高者1.6%；女性患病率5.3%,其中TSH降低者0.8%,TSH升高者4.5%。④与TSH正常组相比,女性TSH升高组和降低组的血尿酸均显著升高(P<0.001)。⑤TSH升高是高尿酸血症的独立影响因素(OR值男性为1.93、女性为1.97,P<0.001)。结论高尿酸血症患病率与TSH升高独立相关,临床或亚临床甲状腺功能减退症可能是高尿酸血症的危险因素。
目的探讨亚临床甲状腺功能减退症对血管内皮功能的影响。方法对70例30-55岁经健康体检无显著心血管疾病或甲状腺手术史者(其中35例甲状腺功能正常对照者,35例TSH 4.7-9.9mU／L的亚临床甲状腺功能减退症者),应用高分辨率超声显像法检测其肱动脉血管内皮依赖性舒张功能。结果两组的肱动脉内径基础值(分别为3.82±0.25mm和3.83±0.25mm)及含服硝酸甘油后肱动脉内径变化百分率(分别为17.8%±5.5%和17.3%±5.4%),均无显著性差异,亚临床甲状腺功能减退症组反应性充血后肱动脉内径变化的百分率(16.0%±4.5%)较正常对照组(16.4%±6.7%)也无显著降低(P>0.05)。结论轻中度亚临床甲状腺功能减退症患者不存在血管内皮功能障碍,TSH升高本身可能不是心血管病的直接危险因素。
Objective To estimate the prevalence of thyroid dysfunction among the staff of a Petrochemical Corporation in Ningbo. Methods A population survey was conducted.10461 workers (including retired workers) were enrolled. Their medical history were investigated by questionairys,and blood samples were collected for thyroid function detection. Results In this petrochemical employees cohort, the prevalences of thyroid dysfunctions were 4.62%,2.70% and 9.11% in total population, male and female, repectively, while the standardized rates were 2.95%,2.06% and 5.31%, accordingly. The prevalence of diagnosed thyroid diseases was 1.81%,0.86% in male and 4.09% in female. Twenty-five percent of individuals with thyroid surgery or medications had abnormal thyroid function. The prevalence of unrecognized thyroid dysfunctions was 2.87%,1.88% in male and 5.29% in female. Subclinical hypothyroidism accounted for 81.7% of unrecognized thyroid dysfunctions.The prevalence of subclincical hypothyroidism was higher in aged people over 70 yrs than in other ages. Conclusions The prevalence of thyroid dysfunctions was over 4.5% in all workers of a Petrochemical Corporation in Ningbo. Subclinical hypothyroidism was the most popular form in all kinds of unrecognized thyroid functional disorders. The prevalence of subclinical hypothyroidism increased with age and was higher in female than in male.
Objective To estimate the prevalence of thyroid dysfunctions among the retired staff of a Petrochemical Corporation in Ningbo. Methods A population survey was conducted.1759 retired workers over age 60 years were investigated to participate in a health survey with a questionnaire, and blood samples were collected for thyroid function detection. Results In this elderly cohort, the prevalence of diagnosed thyroid diseases was 3.9%,7.6% in female and 1.9% in male. The prevalence of unrecognized thyroid dysfunctions was 4.7%,6.9% in female and 3.5% in male. The prevalence of total thyroid dysfunctions was 8.5%,14.0% in female and 5.4% in male. Subclinical hypothyroidism accounted for 81.0% of unrecognized thyroid dysfunctions. The prevalence of thyroid dysfunction was higher in elderly people than in non-elderly persons.
Conclusions The prevalence of thyroid dysfunctions was over 10% in the elderly retired workers of a Petrochemical Corporation in Ningbo. Subclinical hypothyroidism was the most popular form in all kinds of unrecognized thyroid functional disorders. The prevalence of subclinical hypothyroidism was higher in females than in males.
Objective To explore the prevalence of metabolic syndrome in an occupational population.
Methods The data of totally 10461 employees aged 20-90 collected from a Petrochemical Corporation in Ningbo were analyzed. The prevalence of metabolic syndrome was calculated using the criteria of IDF definition pulished in 2005. Results①The prevalence of central overweight, blood pressure over 130/85 mmHg or hypertension, impaired fasting glucose or diabetes mellitus, low HDL-C, high TG and metabolic syndrome were 21.2%、43.5%、11.1%、12.1%、27.1% and 10.2%.②The standardized prevalence of metabolic syndrome was 5.8%. The prevalence of metabolic syndrome was 10.1% in male and 10.5% in female, while the standardized rates were 5.9% and 5.7%, accordingly.③The prevalence of these diseases were increased with aging, and compared with the people yonger than 40 years old, the prevalence of hyperglucemia, hyertention and metabolic syndrome were 2-9 times higher in the people older than 40. Conclusion High prevalence of metabolic syndrome and its related diseases among the employees were observed in the Petrochemical Corporation in Ningbo.
Objective To study the relationship between the prevalence of thyroid dysfunction and components of metabolic syndrome in Ningbo. Methods A total of 10461 workers aged 20 to 90 years of a Petrochemical Corporation in Ningbo were included. Body mass index (BMI), waist circumference, blood pressure, fasting plasma glucose and lipid profile concentrations were measured in all subjects. Metabolic syndrome was diagnosed according to the International Diabetes Federation (IDF) criteria. Results①The prevalences of metabolic syndrome and overall thyroid dysfunction were 10.2% and 4.6%, respectively.②About one fifth of petrochemical employees had abdominal obesity with at least one component of metabolic syndrome.③There was no significant difference in the prevalence of metabolic syndrome within lowered TSH, normal TSH and elevated TSH groups.④Logistic regression analyses revealed that low HDL-C was associated with lowered TSH (OR=2.808,95%CI:1.632-4.833), and high TG was associated with elevated TSH (OR=1.483,95%CI:1.128-1.950).⑤There were significant correlations between serum TSH levels and lipid parameters such as TC in males, TG and LDL-C in females, and HDL-C in both gender. Conclusion The prevalence of thyroid dysfunction was not associated with central obesity, hypertension and hyperglycemia. Lipid disorder was correlation with serum TSH levels.
Objective To study the relationship between the prevalence of hyperuicemia and thyroid dysfunction. Methods 10461 active and retired workers aged 20 to 90 years of a Petrochemical Corporation in Ningbo were included. Serum thyroid-stimulatin hormone (TSH), free thyroxine (FT4), free triiodothyronine (FT3) and serum uric acid (SUA) were measured. Results①The prevalence of hyperuricemia was 18.9% in total workers,23.6% in males and 7.7% in females, respectively.②The prevalence of former diagnosed thyroid diseases was 1.8% in total,0.8% in males and 4.1% in females, respectively.③In 10272 individuals without a history of thyroid disease, the prevalence of thyroid dysfunction was 2.9% in total,1.9%in males and 5.3% in females, respectively. The percentage of subjects with a low TSH concentration was 0.3% in males and 0.8% in females; the percentage of subjects with an elevated TSH concentration was 1.6% in males and 4.5% in females.④Compared with normal TSH workers, the serum uric acid was significantly increased in subjects with either high TSH or low TSH (P<0.001) in females.⑤Logistic regression analysis revealed that low TSH was an independent factor associated with hyperuricemia (OR=1.93 for males and 1.97 for females, P all<0.001, respectively). Conclusion The prevalence of hyperuricemia was independently associated with increased TSH concentration. Overt or subclinical hypothyroidism may be risk factors for hyperuricemia.
Objective To study the effect of mild subclinical hypothyroidism on the endothelium-dependent relaxing function in middle-aged persons. Methods Seventy participants in middle-aged persons without cardiovascular disease and thyroid surgry history were included in this study. Thirty-five of them with normal thyroid function and the others with little-mild subclinical hypothyroidism (TSH 4.7-9.9 mU/L). Endothelial-dependent relaxing function was measured with high-resolution B-mode ultrasound in all participants. Results Flow-mediated dilatation was not significantly impaired in the group of mild subclinical hypothyroidism compared with matched controls with normal thyoid function (16.0%±4.5% vs 16.4%±6.7%, P>0.05). There were no significant difference in baseline (3.82±0.25 mm vs 3.83±0.25 mm) and the nitroglycerin-induced dilatation (17.8%±5.5% vs 17.3%±5.4%) in two groups. Conclusion Endothelium-dependent relaxing function was not impaired in middle-aged patients with mild subclinical hypothyroidism, and mild increased TSH levels may not as a direct risk factor of cardiovascular disease.
引文
[1]Sawin CT. Werner & Ingbar's The Thyroid. Philadelphia, USA:Lippincott Williams & Wilkins,2000,3-6
[2]Reaven GM. Banting Lecture 1988:Role of insulin resistance in human disease. Diabetes,1988,37 (12): 1595-1607
[3]Klein I. Thyroid hormone and the cardiovascular system. The American Journal of Medicine,1990,88 (6): 631-637
[4]Boelaert K, Franklyn JA. Thyroid hormone in health and disease. The Journal of Endocrinolgy,2005,187 (1): 1-5
[5]Duntas LH, Wartofsky L. Cardiovascular risk and subclinical hypothyroidism:focus on lipids and new emerging risk factors. What is the evidence? Thyroid,2007,17 (11):1075-1084
[6]Bell RJ, Rivera-Woll L, Davison SL, Topliss DJ, Donath S, Davis SR. Well-being, health-related quality of life and cardiovascular disease risk profile in women with subclinical thyroid disease-a community-based study. Clinical Endocrinology,2007,66 (4):548-556.
[7]Uzunlulu M, Yorulmaz E, Oguz A. Prevalence of subclinical hypothyroidism in patients with metabolic syndrome. Endocrinology Journal,2007,54 (1):71-76
[8]Klein I, Ojamaa K. Thyroid hormone and the cardiovascular system. The New England Journal of Medicine, 2001,344 (7):501-509
[9]Klein I, Ojamaa K.Thyrotoxicosis and the heart. Endocrinology and Metabolism Clinics of North America, 1998,27(1):51-62
[10]Cooper D, Halpern R, Wood LC, Lavin AA, Ridgway EC. L-thyroxine therapy in subclinical hypothyroidism:a double-blind, placebo-controlled trial. Annals of Internal Medicine,1984,101 (1):18-24
[11]Bakker SJ, TerMaaten JC, Popp-Snijders C, Slaets JP, Heine RJ, Gans RO. The relationship between thyrotropin and low density lipoprotein cholesterol is modified by insulin sensitivity in healthy euthyroid subjects. The Journal of Clinical Endocrinology and Metabolism,2001,86 (3):1206-1211
[12]Surks MI, Ortiz E, Daniels GH, Sawin CT, Col NF, Cobin RH, Franklyn JA, Hershman JM, Burman KD, Denke MA, Gorman C, Cooper RS, Weissman NJ. Subclinical thyroid disease:scientific review and guidelines for diagnosis and management. The Journal of Amerian Medical Association,2004,291 (2): 228-238
[13]单忠艳,滕卫平,李玉妹,王占乙,金迎,关海霞,滕晓春,杨帆,高天舒,王微波,史晓光,佟雅洁,陈威.碘致甲状腺功能减退症的流行病学对比研究.中华内分泌代谢杂志,2001,17(2)：71-74
[14]杨帆,滕卫平,单忠艳,王占乙,金迎,关海霞,胡凤楠,滕晓春,高天舒,王微波,史晓光,佟雅洁,陈威,杨世明,崔炳元.不同碘摄入量地区甲亢的对比流行病学研究.中华内分泌代谢杂志,2001,17(4)：197-201
[15]关海霞,滕卫平,杨世明,崔炳元,单忠艳,金迎,滕晓春,杨帆,高天舒,王微波,史晓光,佟雅洁.
不同碘摄入量地区甲状腺癌的流行病学研究.中华医学杂志,2001,81(8)：457-458
[16]王微波,金迎,滕卫平,单忠艳,李玉姝,高天舒,关海霞,杨帆,滕晓春,史晓光,佟雅洁,陈威,滕笛.不同碘摄入量地区正常人群血清TSH水平的流行病学对比研究.中华内分泌代谢杂志,2002,18(5)：355-356
[17]佟雅洁,滕卫平,金迎,李玉姝,关海霞,王微波,高天舒,滕晓春,杨帆,史晓光,陈威,满娜,李智,国秀娟.不同碘摄入量地区硒与甲状腺功能关系的流行病学研究.中华医学杂志,2003,83(23)：2036-2039
[18]滕晓春,滕笛,单忠艳,关海霞,李玉姝,于晓会,范晨玲,崇巍,杨帆,何力,刘华,温松臣,戴红,毛金媛,谷晓岚,于扬,李佳,陈彦彦,赵冬,杨榕,姜雅秋,李晨阳,滕卫平.碘摄入量增加对甲状腺疾病影响的五年前瞻性流行病学研究.中华内分泌代谢杂志,2006,22(6)：512-517
[19]杨帆,李佳,单忠艳,滕晓春,滕笛,关海霞,李玉姝,崇巍,于晓会,范晨玲,戴红,于扬,毛金媛,何力,陈彦彦,赵冬,滕卫平.不同碘摄入量社区甲状腺功能亢进症的五年流行病学随访研究.中华内分泌代谢杂志,2006,22(6)：518-522
[20]杨帆,李佳,单忠艳,滕晓春,滕笛,关海霞,李玉姝,崇巍,于晓会,范晨玲,戴红,于扬,毛金媛,何力,陈彦彦,赵冬,滕卫平.不同碘摄入量社区甲状腺功能亢进症的五年流行病学随访研究.中华内分泌代谢杂志,2006,22(6)：523-527
[21]戴红,单忠艳,滕晓春,滕笛,关海霞,李玉姝,于晓会,范晨玲,崇巍,杨帆,刘华,温松臣,谷晓岚,毛金媛,于扬,李佳,陈彦彦,赵冬,杨榕,姜雅秋,滕卫平.不同碘摄入量社区甲状腺功能减退症的五年随访研究.中华内分泌代谢杂志,2006,22(6)：528-531
[22]Yang F, Teng W, Shan Z, Guan H, Li Y, Jin Y, Hu F, Shi X, Tong Y, Chen W, Yuan B, Wang Z, Cui B, Yang S. Epidemiological survey on the relationship between different iodine intakes and the prevalence of hyperthyroidism. European Journal of Endocrinology,2002,146 (5):613-618
[23]Shan ZY, Li YS, Wang ZY, Jin Y, Guan HX, Hu FN, Teng XC, Yang F, Gao TS, Wang WB, Shi XG, Tong YJ, Chen W, Teng WP. Effect of different iodine intake on the prevalence of hypothyroidism in 3 counties in China. Chinese Medical Journal (English).2005,20,118 (22):1918-1920
[24]Teng W, Shan Z, Teng X, Guan H, Li Y, Teng D, Jin Y, Yu X, Fan C, Chong W, Yang F, Dai H, Yu Y, Li J, Chen Y, Zhao D, Shi X, Hu F, Mao J, Gu X, Yang R, Tong Y, Wang W, Gao T, Li C. Effect of iodine intake on thyroid diseases in China. The New England Journal of Medicine,2006,354 (26):2783-2793
[25]张志利,彭国英,李树堂.太原地区健康体检人群甲状腺功能紊乱患病情况调查.中华内分泌代谢杂志,2002,18(6)：446-448
[26]赵媛,施秉银,都珍玲,徐莉,赵新,范庆利,樊新华,王淑梅,杨建辉,许春云,龚益.2056例成人甲状腺功能及其自身抗体分析.中华内分泌代谢杂志,2004,20(6)：490-492
[27]Ross DS. Serum thyroid-stimulating hormone measurement for assessment of thyroid function and disease. Endocrinology ans Metabolism Clinics of North America,2001,30 (2):245-264
[28]国务院人口普查办公室,国家统计局人口和社会科技统计司.中国2000年人口普查资料.北京：中国统计出版社,2002：570-572
[29]Klein I, Danzi S. Thyroid disease and the heart. Circulation,2007,116 (15):1725-1735
[30]Golden SH, Robinson KA, Saldanha I, Anton B, Ladenson PW. Clinical review:Prevalence and incidence of endocrine and metabolic disorders in the United States:a comprehensive review. The Journal of Clinical Endocrinology and Metabolism,2009,94 (6):1853-1878
[31]Tunbridge WM, Evered DC, Hall R, Appleton D, Brewise M, Clark F, Evans JG, Young E, Bird T, Smith PA. The spectrum of thyroid disease in a community:the Whickham Survey. Clinical Endocrinology,1977,7 (6): 481-493
[32]Hollowell JG, Staehling NW, FlanderWD, Hannon WH, Gunter EW, Spencer CA, Braverman LE. Serum TSH, T4, and thyroid antibodies in the United States population (1988 to 1994):Nation Health and Nutrition Examination Survey (NHANES III). Journal of Clinical Endocrinology and Metabolism,2002,87 (2): 489-499
[33]Canaris GJ, Manowitz NR, Mayor G, Ridgway EC. The Colorado thyroid disease prevalence study. Archives of Internal Medicine,2000,160 (4):526-534
[34]Knudsen N, Jorgensen T, Rasmussen S, Christiansen E, Perrild H. The prevalence of thyroid dysfunction in a population with borderline iodine deficiency. Clinical Endocrinology,1999,51 (3):361-367
[35]Laurberg P, Pedersen KM, Hreidarsson A, Sigfusson N, Iversen E, Knudsen PR. Iodine intake and the pattern of thyroid disorders:a comparative epidemiological study of thyroid abnormalities in the elderly in Iceland and in Jutland, Denmark. The Journal of Clinical Endocrinology and Metabolism,1998,83 (3): 765-769
[36]Vejbjerg P, Knudsen N, Perrild H, Laurberg P, Carle A, Pedersen IB, Rasmussen LB, Ovesen L, Jorgensen T. Lower prevalence of mild hyperthyroidism related to a higher iodine intake in the population:prospective study of a mandatory iodization programme. Clinical Endocrinology,2009,71 (3):440-445
[37]彭雯,王晓东,刘超.碘摄入量与自身免疫性甲状腺疾病关系的研究进展.医学综述,2008,14(16)：522-525
[38]黄学敏,朱文明,姚顺荣,周金水,屠兴国,陈颖.1995-200年浙江省碘缺乏病监测10年结果分析.中国地方病学杂志,2006,25(3)：665-667
[39]Slowinska-Klencka D, KlenckiM, Sporny S, Lewinski A. Fine-needle aspiration biopsy of the thyroid in an area of endemic goitre:influence of restored sufficient iodine supp lementation on the clinical significance of cytological results. European Journal of Endocrinology,2002,146 (1):19-26
[40]Zois C, Stavrou L, Kalogera C, Svarna E, Dimoliatis I, Seferiadis K, Tsatsoulis A. High prevalence of autoimmune thyroiditis in schoolchildren after elimination of iodine deficiency in northwestern Greece. Thyroid,2003,13 (5):485-489
[41]李玉姝,赵冬,单忠艳,滕晓春,滕笛,关海霞,于晓会,范晨玲,崇巍,杨帆,戴红,谷晓岚,于扬,毛金媛,李佳,陈彦彦,杨榕,姜雅秋,李晨阳,滕卫平.不同碘摄入量地区甲状腺自身抗体的流行病学五年随访研究.中华内分泌代谢杂志,2006,22(6)：518-522
[42]Roti E, Uberti ED. Iodine excess and hyperthyroidism.. Thyroid,2001,11 (5):493-500
[43]Markou K, GeorgopoulosN, Kyriazopoulou V, Vagenakis AG. Iodine-induced hypothyroidism. Thyroid, 2001,11 (5):501-510
[44]Weetman AP. Autoimmune thyroid disease:propagation and progression. European Journal of Endocrinology,2003,148 (1):1-9
[45]Ross DS, Daniels GH, Gouveia D. The use and limitations of a chemiluminescent thyrotropin assay as a single thyroid function test in an out-patient endocrine clinic. The Journal of Clinical Endocrinology and Metabolism,1990,71 (3):764-769
[46]Kasagi K, Takahashi N, Inoue G, Honda T, Kawachi Y, Izumi Y. Thyroid function in Japanese adults as assessed by a general health checkup system in relation with thyroid-related antibodies and other clinical parameters. Thyroid,2009,19 (9):937-944
[47]Biondi B, Palmieri EA, Klain M, Schlumberger M, Filetti S, Lombardi G. Subclinical hyperthyroidism: clinical features and treatment options. European Journal of Endocrinology,2005,152 (1):1-9
[48]Fatourechi V, Laukarani M, Schryver PG, Vanness DJ, Long KH, Klee GG. Factors influencing clinical decisions to initiate thyroxine therapy for patients with mildly increased serum thyrotropin (5.1-10.0 mU/L). Mayo Clinical Proceedings,2003,78 (5):554-560
[49]Meier C, Staub JJ, Roth CB, Guglielmetti M, Kunz M, Miserez AR, Drewe J, Huber P, Herzog R, Muller B. TSH-controlled L-thyroxine therapy reduces cholexterol levels and clinical symptoms in subclinical hypothyroidism;a double blind, placebo-controlled trail (basd thyroid study). The Journal of Clinical Endocrinology and Metabolism,2001,86 (10):4860-4866
[50]Fatourechi V. Subclinical thyroid disease. Mayo Clinical Proceedings,2001,76 (4):413-416
[51]Danese MD, Ladenson PW, Meinert CL, Powe NR. Clinical review:effect of thyroxine therapy on serum lipoproteins in patients with mild thyroid failure:a quantitative review of the literature. The Journal of Clinical Endocrinology and Metabolism,2000,85 (9):2993-3001
[52]Franklyn JA, Sheppard MC, Maisonneuve P. Thyroid function and mortality in patients treated for hyperthyroidism. The Journal of American Medical Association,2005,294 (1):71-80
[53]Diez JJ, Iglesias P. Spontaneous subclinical hypothyroidism in patients older than 55 years:an analysis of natural course and risk factors for the development of overt thyroid failure. The Jouranl of Clinical Endocrinology and Metabolism,2004,89 (10):4890-4897
[54]Biondi B, Palmieri EA, Lombardi G, Fazio S. Effects of subclinical thyroid dysfunction on the heart. Annals of Internal Medicine,2002,137 (11):904-914
[55]Arrigo T, Wasniewska M, Crisafulli G, Lombardo F, Messina MF, Rulli I, Salzano G, Valenzise M, Zirilli G, De Luca F. Subclinical hypothyroidism:the state of the art. Journal of Endocrinological Investigation,2008, 31(1):79-84
[56]Estaquio C, Valeix P, Leenhardt L, Modigliani E, Boutron-Ruault MC, Cherie-Challine L, Legrand M, Hercberg S, Castetbon K. Serum thyrotropin and free thyroxine reference ranges as defined in a disease-free sample of French middle-aged adults. Clinical Chemistry and Laboratory Medicine.2009,47 (12):
1497-1505
[57]Takeda K, Mishiba M, Sugiura H, Nakajima A, Kohama M, Hiramatsu S. Evaluated reference intervals for serum free thyroxine and thyrotropin using the conventional outliner rejection test without regard to presence of thyroid antibodies and prevalence of thyroid dysfunction in Japanese subjects. Endocrine Journal,2009,56 (9):1059-1066
[58]Morganti S, Ceda GP, Saccani M, Milli B, Uqolotti D, Prampolini R, Maqqio M, Valenti G, Ceresini G. Thyroid disease in the elderly:sex-related differences in clinical expression. Journal of Endocrinological Investigation,2005,28 (11):101-104
[59]Rehman SU, Cope DW, Senseney AD, Brzezinski W. Thyroid disorders in elderly patients. Southern Medical Journal,2005,98 (5):543-549
[60]Diez JJ, Molina I, Ibars MT. Prevalence of thyroid dysfunction in adults over age 60 years from an urban community. Experimental and Clinical Endocrinology and Diabetes,2003,111 (8):480-485
[61]Boelaert K, Franklyn JA. Thyroid hormone in health and disease. The Journal of Endocrinology,2005,187 (1):1-15
[62]Cappola AR, Fried LP, Arnold AM, Danese MD, Kuller LH, Burke GL, Tracy RP, Ladenson PW. Thyroid status, cardiovascular risk, and mortality in older adult. JAMA,2006,295 (6):1033-1041
[63]Smit JW, Eustatia-Rutten CF, Corssmit EP, Pereira AM, Frolich M, Bleeker GB, Holman ER, van der Wall EE, Romijn JA, Bax JJ. Reversible diastolic dysfunction after long-term exogenous subclinical hyperthyroidism:a randomized, placebo-controlled study. The Journal of Clinical Endocrinology and Metabolism,2005,90 (12):6041-6047
[64]Sheppard MC, Holder R, Franklyn JA. Levothyroxine treatment and occurrence of fracture of the hip. Archives of Internal Medicine,2002,162 (2):338-343
[65]Peeters RP. Thyroid hormones and aging. Hormones,2008,7(1):28-35
[66]Hadj-Kacem H, Rebuffat S, Mnif-Feki M, Belguith-Maalej S, Ayadi H, Peraldi-Roux S. Autoimmune thyroid diseases:genetic susceptibility of thyroid-specific genes and thyroid autoantigens contributions. International Journal of Immunogenetics,2009,36 (2):85-96
[67]Monzani F, Dibello V, Caraccio N, Bertini A, Giorgi D, Giusti C, Ferrannini E. Effect of levothyroxine on cardiac function and stucture. The Journal of Clinical Endocrinology and Metabolism,2001,86 (3): 1110-1115
[68]Biondi B, Fazio S, Palmieri EA, Carella C, Panza N, Cittadini A, Bone F, Lombardi G, Sacca L. Left ventricular diastolic dysfunction in patients with Subclinical hypothyroidism. The Journal of Clinical Endocrinology and Metabolism,1999,84 (6):2064-2067
[69]Hak AE, Pols HA, Visser TJ, Drexhage HA, Hofman A, Witteman JC. Subclinical hypothytoidism is an independent risk factor for athersclerosis and myocardial infarction in elderly women:the Rotterdam Study. Annals of Internal Medicine,2000,132 (4):270-278
[70]Auer J, Berent R, Weber T, Lassnig E, Eber B. Thyroid function is associated with presence and severity of coronary atherosclerosis. Clinical Cardiology,2003,26 (12):569-573
[71]Taddei S, Caraccio N, Virdis A, Dardano A, Versari D, Ghiadoni L, Salvetti A, Ferrannini E, Monzani F. Impaired endothelium-dependent vasodilatation in subclinical hypothyroidism:beneficial effect of levothyroxine therapy. The Journal of Clinical Endocrinology and Metabolism,2003,88 (8):3731-3737
[72]Parle JV, Maisonneuve P, Sheppard MC, Boyle P, Franklyn JA. Prediction of all cause and cardiovascular mortality in elderly people from one low serum thyrotropin result:a 10-year cohort study. The Lancet,2001, 358 (9285):861-865
[73]Milionis HJ, Efstathiadou Z, Tselepis AD, Bairaktari ET, Tsironis LD, Tsatsoulis A, Elisaf MS. Lipoprotein(a) levels and apolipoprotein(a) isoform size in patients with subclinical hypothyroidism:effect of treatment with levothyroxine. Thyroid,2003,13 (4):365-369
[74]Vanderpump MP, Tunbridge WM, French JM, Appleton D, Bates D, Clark F, Grimley Evans J, Hasan DM, Rodgers H, Tunbridge F. The incidence of thyroid disorders in the community:a twenty-year follow-up of the Whickham Survey. Clinical Endocrinology,1995,43 (1):55-68.
[75]Williams CM. Using medications appropriately in older adults. American Family Physician,2002,66 (10): 1917-1924
[76]Zimmet P, Magliano D, Matsuzawa Y, Alberti G, Shaw J. The metabolic syndrome:a global public health problem and a new definition. Journal of Atherosclerosis and Thrombosis,2005,12 (6):295-300
[77]朱禧星.胰岛素抵抗,代谢综合征与胰岛素增敏剂.中华内分泌代谢杂志,2000,16(6)：333-334
[78]Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1:diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabetic Medicine,1998,15 (7):539-553
[79]Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, Taskinen MR, Groop L. Cardiovascular morbidity and mortality associated with the metabolic Syndrome. Diabetes Care,2001,24 (4):683-689
[80]Trevisan M, Liu J, Bahsas FB, Menotti A. Syndrome X and mortality:a population-based study. American Journal of Epidemiology,1998,148 (10):958-966
[81]National Cholesterol Education Program (NCEP):Expert Panel on Detection and Treatment of High Blood Cholesterol in Adults. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel Ⅲ) final report. Circulation,2002,106 (25):3143-3421
[82]Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, Spertus JA, Costa F; American Heart Association; National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome:an American Heart Association/National Heart, Lung and Blood Institute scientific statement. Circulation,2005,112(17):2735-2752
[83]中华医学会糖尿病分会关于代谢综合征研究协作组.中华医学会糖尿病分会关于代谢综合征的建议.中华糖尿病杂志,2004,12(3)：156-161
[84]Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults. The Journal of American Medical Association,2002,287 (3):356-359
[85]Ervin RB. Prevalence of metabolic syndrome among adults 20 years of age and over, by sex, age, race and ethnicity, and body mass index:United States,2003-2006. National Health Statistics Reports,2009,5 (13): 1-7
[86]Huang PL. A comprehensive definition for metabolic syndrome. Disease Models and Mechanism,2009,2 (5-6):231-237
[87]张毅,李玲,厉平,王贵新.不同代谢综合征诊断标准在沈阳地区人群中的比较.中国医科大学学报,2007,36(2)：86-87
[88]李济宾,古萍,张晋昕,张熙,陈彩霞,王勃维,洪令瑶,李娟,雷迪,李明凤.代谢综合征三种诊断标准在广东省人群中的应用对比.中国健康教育,2008,24(2)：113-116
[89]刘庆敏,施世锋,施文英,李莉,陈仁华,裘欣,张楚,方顺源,金达丰.杭州市成人代谢综合征及其各组分患病率分析.中国预防医学杂志,2008,9(1)：18-21
[90]罗不凡,杜琳,潘冰莹,陈健,徐健敏,王建华.广州市1 5岁以上居民代谢综合征流行特征分析.中国糖尿病杂志,2008,16(5)：267-270
[91]邵继红,王坤,沈霞,李东野,李翔,方晓芬,何庆峰,刘微微,任香梅,张美荣,金英良.徐州市居民代谢综合征患病率调查.中国公共卫生,2008,24(9)：1118-1119
[92]吴元民,邵宝蓉,顾惠琳,袁杏生,刘绍芳,贾伟平,项坤三.上海市华阳社区糖尿病、高血压、血脂紊乱及代谢综合征基线调查.上海医学,2001,24(4)：195-198
[93]姜素英,章晖,左玉华,刘兰花,原永明,方蓉,蔡伟青,贾伟平,项坤三.上海市曹杨社区20岁以上人群代谢综合征及其相关疾病的流行病学调查.上海医学,2003,26(1)：3-6
[94]冯波,李栩,黄亦文,乐秀康,富明,陈明慧,戴明德,倪亚芳,赵竹芳,周凤英,孟仲莹,王惠玲,姚国良,张容,刘昊,张小倩.上海市浦东新区社区人群代谢综合征状况和相关危险因素分析.中华内分泌代谢杂志,2004,20(3)：231-232
[95]Park YW, Zhu S, Palaniappan L, Heshka S, Carnethon MR, Heymsfield SB. The metabolic syndrome: Prevalence and associated risk factor findings in the US population from the third national health and nutrition examination survey. Archives of Internal Medicine,2003,163 (4):427-436
[96]Kahn R, Buse J, Ferrannini E, Stern M; American Diabetes Association; European Association for the Study of Diabetes. The metabolic syndrome:time for a critical appraisal:joint statement from the American Diabetes Association and the European Association for the study of diabetes. Diabetes Care,2005,28 (9):2289-2304
[97]顾东风,Reynolds K,杨文杰,陈恕凤,吴锡桂,段秀芳,蒲晓东,徐丽华,吴先萍,陈祥福,魏仁敏,陈娜萦,吴天一,王礼桂,姚才良,牟建军,马义峰,王晓飞,Whelton P,何江.中国成年人代谢综合征的患病率.中华糖尿病杂志,2005,13(3)：181-186
[98]脑卒中、冠心病发病危险因素进一步研究协作组.11省市队列人群代谢综合征的流行病学研究.中华预防医学杂志,2002,36(5)：298-300
[99]任振勇,黄磊,庞星火,贾娜.北京市成人代谢综合征及其影响因素分析.中国公共卫生,2005,21(8)： 981-921
[100]卢伟,刘美霞,李锐,傅华,金泰廙,张胜年.上海15-74岁居民代谢综合征的流行特征.中华预防医学杂志,2006,40(4)：262-268
[101]Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, Bonadonna RC, Muggeo M; Bruneck study. Carotid atherosclerosis and coronary heart disease in the metabolic syndrome:prospective data from the Bruneck Study. Diabetes Care,2003,26 (4):1251-1257
[102]Grundy SM, Hansen B, Smith SC Jr, Kahn RA; American Heart Association; National Heart, Lung, and Blood Institute; American Diabetes Association. Definition of metabolic syndrome:report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation,2004,109 (3):433-438
[103]Ninomiya JK, L'Italien G, Criqui MH, Whyle JL, Gamst A, Chen RS. Association of the metabolic syndrome with history of myocardial infarction and stroke in the third national health and nutrition examination survey. Circulation,2004,109 (1):42-46
[104]Klein BE, Klein R, Lee KE. Components of the metabolic syndrome and risk of cardiovascular disease and diabetes in beaver dam. Diabetes Care,2002,25 (10):1790-1794
[105]Deedwania PC. Metabolic syndrome and vascular disease:is nature or nature leading the new epidemic of cardiovascular disease? Circulation,2004,109 (1):2-4
[106]Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, Taskinen MR, Groop L. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care,2001,24 (4):683-689
[107]Resnick HE, Jones K, Ruototo G, Jain AK, Henderson J, Lu W, Howard BV; Strong Heart Study. Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease in nondiabetic American Indians:the Strong Heart Study. Diabetes Care,2003,26 (3):861-867
[108]Carr MC, Brunzell JD. Abdominal obesity and dyslipidemia in the metabolic syndrome:importance of type 2 diabetes and familial combined hyperlipidemia in coronary artery disease risk. The Journal of Clinical Endocrinology and Metabolism,2004,89 (6):2601-2607
[109]Anand SS, Yi Q, Gerstein H, Lonn E, Jacobs R, Vuksan V, Teo K, Davis B, Montague P, Yusuf S; Study of Health Assessment and Risk in Ethnic Groups; Study of Health Assessment and Risk Evaluation in Aboriginal Peoples Investigators. Relationship of metabolic syndrome and fibrinolytic dysfunction to cardiovascular disease. Circulation,2003,108 (4):420-425
[110]Grundy SM, Hansen B, Smith SC Jr, Cleeman JI, Kahn RA; American Heart Association; National Heart, Lung, and Blood Institute; American Diabetes Association. Clinical management of metabolic syndrome: report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management. Circulation,2004,109 (4):551-556
[111]Alberti KG, Zimmet P, Shaw J. The metabolic syndrome-a new worldwide definition. The Lancet,2005, 366(9491):1059-1062
[112]Boden G. Effect s of free fatty acids (FFA) on glucose metabolism:significance for insulin resistance and type 2 diabetes. Experimental and Clinical Endocrinology and Diabetes,2003,111 (3):121-124
[113]Chien KL, Hsu HC, Sung FC, Su TC, Chen MF, Lee YT. Metabolic syndrome as a risk factor for coronary heart disease and stroke:an 11-year prospective cohort in Taiwan community. Atherosclerosis,2007,194 (1):214-221
[114]Wang J, Ruotsalainen S, Moilanen L, Lepisto P, Laakso M, Kuusisto J. The metabolic syndrome predicts cardiovascular mortality:a 13-year follow-up study in elderly nondiabetes Finns. European Heart Journal, 2007,28 (7):857-864
[115]Simons LA, Simons J, Friedlander Y, McCallum J. Does a diagnosis of the metabolic syndrome provide additional prediction of cardiovascular disease and total mortality in the elderly? The Dubbo Study. The Medical Journal of Australia,2007,186 (8):400-403
[116]Danzi S, Klein I. Thyroid hormone and blood pressure regulation. Current Hypertension Reports,2003,5 (6):523-520
[117]Duntas LH. Thyroid disease and lipids. Thyroid,2002,12 (4):287-293
[118]Fommei E, Iervasi G. The role of thyroid hormone in blood pressure homeostasis:evidence from short-term hypothyroidism in humans. The Journal of Clinincal Endocrinology and Metabolism,2002,87 (5):1996-2000
[119]Cappola AR, Ladenson PW. Hypothyroidism and atherosclerosis. Journal of Clinical Endocrinology and Metabolism,2003,88 (6):2438-2444
[120]Takashima N, Niwa Y, Mannami T, Tomoike H, Iwai N. Characterization of subclinical thyroid dysfunction from cardiovascular and metabolic viewpoints:The Suita Study. Circulation Journal,2007,71 (2):191-195
[121]Jung CH, Sung KC, Shin HS, Rhee EJ, Lee WY, Kim BS, Kang JH, Kim H, Kim SW, Lee MH, Park JR, Kim SW. Thyroid dysfunction and their relation to cardiovascular risk factors such as lipid profile, hsCRP, and waist hip ratio in Korea. Korean Journal of Internal Medicine,2003,18 (3):146-153
[122]Teixeira PF, Reuters VS, Ferreira MM, Almeida CP, Reis FA, Melo BA, Buescu A, Costa AJ, Vaisman M. Treatment of subclinical hypothyroidism reduces atherogenic lipid levels in a placebo-controlled double-blind clinical trial. Hormone and Metabolic Research,2008,40 (1):50-55
[123]BindelsAJ, Westendorp RG, FrolichM, Seidell JC, Blokstra A, Smelt AH. The prevalence of subclinical hypothyroidism at different total plasma cholesterol levels in middle men and women:a need for case-finding. Clinical Endocrinology,1999,50 (2):217-220
[124]Samuels MH. Subclinical thyroid disease in the elderly. Thyroid,1998,8 (9):803-813
[125]Biondi B, Cooper DS. The clinical significance of subclinical thyroid dysfunction. Endocrine Reviews, 2008,29(1):76-131
[126]Takashima N, Niwa Y, Mannami T, Tomoike H, Iwai N. Characterization of subclinical thyroid dysfunction from cardiovascular and metabolic viewpoints:the Suita study. Circulation Journal,2007,71 (2): 191-195
[127]Knudsen N, Laurberg P, Rasmussen LB, Bulow I, Perrild H, Ovesen L, Jorgensen T. Small differences in thyroid function may be important for body mass index and the occurrence of obesity in the population. The Journal of Clinical Endocrinology and Metabolism,2005,90 (7):4019-4024
[128]Nyrnes A, Jorde R, Sundsfjord J. Serum TSH is positively associated with BMI. International Journal of Obesity,2006,30 (1):100-105
[129]Shon HS, Jung ED, Kim SH, Lee JH. Free T4 is negatively correlated with body mass index in euthyroid women. Korean Journal of Internal Medicine,2008,23 (2):53-57
[130]Michalaki MA, Vagenakis AG, Leonardou AS, Argentou MN, Habeos IG, Makri MG, Psyrogiannis AI, Kalfarentzos FE, Kyriazopoulou VE. Thyroid function in humans with morbid obesity. Thyroid,2006,16(1): 73-78
[131]Manji N, Boelaert K, Sheppard MC, Holder RL, Gough SC, Franklyn JA. Lack of association between serum TSH or free T4 and body mass index in euthyroid subjects. Clinical Endocrinology,2006,64 (2): 125-128
[132]Isozaki O, Tsushima T, Nozoe Y, Miyakawa M, Takano K. Leptin regulation of the thyroids:negative regulation on thyroid hormone levels in euthyroid subjects and inhibitory effects on iodide up take and Na+/I-symporter mRNA expression in rat FRTL-5 cells. Endocrine Journal,2004,51(4):415-423
[133]Cabanelas A, Lisboa PC, Moura EG, Pazos-Moura CC. Acute effects of leptin on 5'-deiodinases are modulated by thyroid state of fed rats. Hormone and Metabolic Research,2007,39 (11),818-822
[134]Dernellis J, Panaretou M. Effects of thyroid replacement therapy on arterial blood pressure in patients with hypertension and hypothyroidism. American Heart Journal,2002,143 (4):718-724
[135]Walsh JP, Bremner AP, Bulsara MK. Subclinical thyroid dysfunction and blood pressure:a community2based study. Clinical Endocrinology,2006,65 (4):486-491
[136]Duan Y, Peng W, Wang X, Tang W, Liu X, Xu S, Mao X, Feng S, Feng Y, Qin Y, Xu K, Liu C, Liu C. Community-based study of the association of subclinical thyroid dysfunction with blood pressure. Endoucrine,2009,35 (2):136-142
[137]Asvold BO, Bj(?)ro T, Nilsen TI, Vatten LJ. Association between blood pressure and serum thyroid-stimulating hormone concentration within the reference range:a population-based study. The Journal of Clinical Endocrinology and Metabolism,2007,92 (3):841-845
[138]毛玉山,周丽诺,李福军,叶红英,杜娟,施淑钧,陈长喜,申定国,黄童,洪中立.中老年高尿酸血症对血管内皮功能的影响.中华风湿病学杂志,2006,10(3)：169-171
[139]See LC, Kuo CF, Chuang FH, Li HY, Chen YM, Chen HW, Yu KH. Serum uric acid is independently associated with metabolic syndrome in subjects with and without a low estimated glomerular filtration rate. The Journal of Rheumatology,2009,36 (8):1691-1698
[140]Giordano N, Santacroce C, Mattii G, Geraci S, Amendola A, Gennari C. Hyperuricemia and gout in thyroid endocrine disorders. Clinical and Experimental Rheumatology,2001,19 (6):661-665
[141]蒋明,Yu D,林孝义.中华风湿病学.北京：华夏出版社,2004,1215-1227
[142]Kuzzel WC, Schaffarzick RW, Naugler WE. Some observations on 520 gouty patients. The Journal of Chronic Disease,1955,2 (1):64-68
[143]Sato A, Shirota T, Shinoda T, Komiya I, Aizawa T, Takemura Y, Yamada T. Hyperuricemia in patients with hyperthyoidism due to Graves' disease. Metabolism,1995,44 (2):207-211
[144]Boyle JA, Greig WR, Duncan AM, Boyle IT, Buchanan WW. Serum uric acid values in various states of thyroid function. Acta Rheumatologic Scandinavica,1966,12 (3):204-209
[145]Mikkelsen WM, Dodge HJ, Valkenburg H. The distribution of serum uric acid values in a population unselectde as to gout or hyperuricemia. The American Journal of Medicine,1965,39 (2):242-251
[146]毛玉山,周丽诺,叶红英,黄童,陈长喜,杜娟,洪中立,胡仁明.宁波市某石化企业员工高尿酸血症和痛风患病率调查.中华内分泌代谢杂志,2006,22(8)：338-341
[147]Ford HC, Lim WC, Chisnall WN, Pearce JM. Renal function and electrolyte levels in hyperthyroidism: urinary protein excretion and the plasma concentration of urea, creatinine, uric acid, hydrogen ion and electrolytes. Clinical Endocrinology,1989,30 (3):293-301
[148]Shirota T, Shinoda T, Yamada T, Aizawa T. Alteration of renal function in hyperthyroism:increased tubular secretion of creatinie and decreased distal tubule delivery of chloride. Metabolism,1992,41 (4):402-405
[149]Kutzing MK, Firestein BL. Altered uric acid levels and disease states. The Journal of Pharmacology and Experimental Therapeutics,2008,324 (1):1-7
[150]石恩荣.高尿酸血症与高血压关系的探讨.右江民族医学院学报,2006,28(1)：37-38
[151]朱君,徐俊文.高尿酸血症和痛风的流行病学及其危险因素的研究进展.现代生物医学进展,2008,8(1)：191-195
[152]Bo S, Cavallo-Perin P, Gentile L, Repetti E, Pagano G. Hypouricemia and hyperuricemia in type 2 diabetes: two different phenotypes. European Journal of Clinical Investigation,2001,31 (4):318-321
[153]Oyama C, Takahashi T, Oyamada M, Oyamada T, Ohno T, Miyashita M, Saito S, Komatsu K, Takashina K, Takada G Serum uric acid as an obesity-related indicator in early adolescence. The Tohoku Journal of Experimental Medicine,2006,209 (3):257-262
[154]Puig JG, Martinez MA. Hyperuricemia, gout and the metabolic syndrome. Currernt Opinion in Rheumatology,2008,20 (2):187-191
[155]Mooraki A, Bastani B. Reversible renal insufficiency, hyperuricemia and gouty arthritis in a case of hypothyroidism. Clinical Nephrology,1998,49 (1):59-61
[156]Bonetti PO, Lerman LO, Lerman A. Endothelial dysfunction:a marker of atherosclerotic risk. Arteriosclerosis, Thrombosis, and Vasculai Biology,2003,23 (2):168-175
[157]Biondi B, Galderisi M, Pagano L, Sidiropulos M, Pulcrano M, D' Errico A, Ippolito S, Rossi A, de Divitiis O, Lombardi G. Endothelial-mediated coronary flow reserve in patients with mild thyroid hormone deficiency. European Journal of Endocrinology,2009,161 (2):323-329
[158]Balletshofer BM, Rittig K, Rett K, Haring HU, Nawroth PP. Flow associated (endothelium dependent) vasodilation and TSH-levels in young normotensive and normoglycemic subjects. The Journal of Vascular Disease,2001,30 (2):97-100
[159]Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID, Lloyd JK, Deanfield JE. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. The Lancet,1992,340 (8828):1111-1115
[160]van Zaane B, Reuwer AQ, Buller HR, Kastelein JJ, Gerdes VE, Twickler MT. Hormones and cardiovascular disease:a shift in paradigm with clinical consequences? Seminars in Thrombosis and Hemostasis,2009,35 (5):478-487
[161]Cooke JP. The endothelium:a new target for therapy. Vascular Medicine,2000,5 (1):49-53
[162]Verma S, Buchanan MR, Anderson TJ. Endothelial function testing as a biomarker of vascular disease. Circulation,2003,108 (17):2054-2059
[163]Takase B, Uehata A, Akima T, Nagai T, Nishioka T, Hamabe A, Satomura K, Ohsuzu F, Kurita A. Endothelium-dependent flow-mediated vasodilation in coronary and brachial arteries in suspected coronary artery disease. The American Journal of Cardiology,1998,82 (12):1535-1539
[164]Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA, Deanfield J, Drexler H, Gerhard-Herman M, Herrington D, Vallance P, Vita J, Vogel R; International Brachial Artery Reactivity Task Force. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery:a report of the International Brachial Artery Reactivity Task Force. Journal of the American College of Cardiology,2002,39 (2):257-265
[165]Yeboah J, Crouse JR, Hsu FC, Burke GL, Herrington DM. Brachial flow-mediated dilation predicts incident cardiovascular events in older adults:The Cardiovascular Health Study. Circulation,2007,115 (18):2390-2397
[166]Yeboah J, Burke GL, Crouse JR, Herrington DM. Relationship between brachial flow-mediated dilation and carotid intima-media thickness in an elderly cohort. Atherosclerosis,2008,197 (2):840-845
[167]Matsushima Y, Takase B, Uehata A, Kawano H, Yano K, Ohsuzu F, Ishihara M, Kurita A. Comparative predictive and diagnostic value of flow2mediated vasodilation in the brachial artery and intima media thickness of the carotid artery for assessment of coronary artery severity. International Journal of Cardiology, 2007,117 (2):165-172
[168]Cabral MD, Teixeira PF, Silva NA, Morais FF, Soares DV, Salles E, Henriques JM, Leite SP, Montenegro CA, Vaisman M. Normal flow-mediated vasodilatation of the brachial artery and carotid artery intima-media thickness in subclinical hypothyroidism. Brazilian Journal of Medical and Biological Research,2009,42 (5): 426-432
[169]Xiang GD, He YS, Zhao LS, Hou J, Yue L, Xiang HJ. Impairment of endothelium-dependent arterial dilation in Hashimoto's thyroiditis patients with euthyroidism. Clinical Endocrinology,2006,64 (6): 698-702
[170]Papaioannou GI, Lagasse M, Mather JF, Thompson PD. Treating hypothyroidism improves endothelial function. Metabolism,2004,53 (3):278-279
[171]Cooper DS. Subclinical hypothyroidism. The New England Journal of Medicine,2001,345 (4):260-265
[172]滕卫平.开展亚临床甲状腺功能减退症的临床研究.中华内分泌代谢杂志,2004,20(2)：93-95
[173]胡玲,舒秉俊,邬国和,孙掌花,罗一湛,张建华,甘道龙,邱明琪.南昌地区亚临床甲状腺功能减退症的筛查分析.中华内分泌代谢杂志,2002,18(2)：127-129
[174]滕卫平.亚临床甲状腺功能减退症.国外医学内分泌学分册,2003,23(6)：370-372
[175]Munteis E, Cano JF, Flores JA, Martinez-Rodriguez JE, Miret M, Roquer J. Prevalence of autoimmune thyroid disorders in a Spanish multiple sclerosis cohort. European Journal of Neurology,2007,14 (9): 1048-1052
[176]Rivolta G, Cerutti R, Colombo R, Miano G, Dionisio P, Grossi E. Prevalence of subclinical hypothyroidism in a population living in the Milan metropolitan area. Journal of Endocrinological Investigation,1999,22 (9): 693-697
[177]Szabolcs I, Podoba J, Feldkamp J, Dohan O, Farkas I, Sajgo M, Takats KI, Goth M, Kovacs L, Kressinszky K, Hnilica P, Szilagyi G. Comparative screening for thyroid disorders in old age in areas of iodine deficiency, long-term iodine prophylaxis and abundant iodine intake. Clinical Endocrinology,1997,47 (1):87-92
[178]Roberts CG, Ladenson PW. Hypothyroidism. The Lancet,2004,363 (9411):793-803
[179]Huber G, Mitrache C, Meier C, Guglielmetti M, Huber P, Staub JJ. Long-term study of subclinical hypothyroidism:spontaneous course and predictor of manifest hypothyroidism. Schweizerische Medizinische Wochenschrift,1998,128 (48):2902-2905
[180]Singer P. Primary hypothyroidism due to other causes. In:Braverman LE, Utiger RD. Werner, Ingbar's the thyroid:a fundamental and clinical text. Philadelphia:Lippincott, Williams & Wilkins,2005,745-754
[181]Ayala AR, Danese MD, Ladenson PW. When to treat mild hypothyroidism. Endocrinology and Metabolism Clinics of North America,2000,29 (2):399-415
[182]Michael W, Tunbridge G, Vanderpump MP. Population screen for autoimmue thyroid disease. Endocrinology and Metabolism Clinics of North America,2000,29 (2):239-254
[183]史晓光,崇巍威,滕卫平,单忠艳,李玉姝,关海霞,滕晓春,佟雅洁,陈威,李智,满娜,滕笛.93例亚临床甲状腺功能减退症的随访研究.中华内分泌代谢杂志,2003,19(2)：86-88
[184]郑兵.甲状腺功能检测指标临床意义.实用内科杂志,2006,13(4)：547-548
[185]Huber G, Staub JJ, Meier C, Mitrache C, Guglielmetti M, Huber P, Braverman LE. Prospective study of the spontaneous course of subclinical hypothyroidism:prognostic value of thyrotropin, thyroid reserve, and thyroid antibodies. The Journal of Clinical Endocrinology and Metabolism,2002,87 (7):3221-3226
[186]Klein I, Ojamaa K. Thyroid hormone and the cardiovascular system. The New England Journal of Medicine,2001,344 (7):501-509
[187]Sawin CT, Geller A, Wolf PA, Belange AJ, Baker E, Bacharach P, Wilson P, Benjamin EJ, D'Agostino RB. Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. The New England Journal of Medicine,1994,331 (19):1249-1252
[188]Vanderpump MP, Tunbridge WM, French JM, Appleton D, Bates D, Clark F, Grimley Evans J, Rodgers H, Tunbridge F, Young ET. The development of ischemic heart disease in relation to autoimmune thyroid disease in a 20-year follow-up study of an English community. Thyroid,1996,6 (3):155-160
[189]Walsh JP, Bremner AP, Bulsara MK, O'Leary P, Leedman PJ, Feddema P, Michelangeli V. Subclinical thyroid dysfunction as a risk factor for cardiovascular disease. Archives of Internal Medicine,2005,165 (21): 2467-2472
[190]Sgarbi J, Matsumura L, Kasamatsu T, Ferreira S, Maciel R. Subclinical thyroid dysfunctions are independent risk factors for mortality in a 7.5-year follow-up:the Japanese-Brazilian thyroid study. European Journal of Endocrinology,2010,162 (3):569-577
[191]Dagre AG, Lekakis JP, Protogerou AD, Douridas GN, Papaioannou TG, Tryfonopoulos DJ, Papamichael CM, Alevizaki M. Abnormal endothelial function in female patients with hypothyroidism and borderline thyroid function. International Journal of Cardiology,2007,114 (3):332-338
[192]Razvi S, Ingoe L, Keeka G, Oates C, McMillan C, Weaver JU. The beneficial effect of L-thyroxine on cardiovascular risk factors, endothelial function, and quality of life in subclinical hypothyroidism: randomized, crossover trial. The Journal of Clinical Endocrinology and Metabolism,2007,92 (5): 1715-1723
[193]Raitakari OT, Celermajer DS. Flow-mediated dilatation. British Journal of Clinical Pharmacology,2000,50 (5):397-404
[194]Christ-Crain M, Meier C, Guglielmetti M, Huber PR, Riesen W,Staub JJ, Muller B. Elevated C-reactive protein and homocysteine values:cardiovascular risk factors in hypothyroidism? A cross-sectional and a double-blind, placebo-controlled trial. Atherosclerosis,2003,166 (2):379-386
[195]Kvetny J, Heldgaard PE, Bladbjerg EM, Gram J. Subclinical hypothyroidism is associated with a low-grade inflammation, increased triglyceride levels and predicts cardiovascular disease in males below 50 years. Clinical Endocrinology,2004,61 (2):232-238
[196]Tuzcu A, Bahceci M, Gokalp D, Tuzun Y, Gunes K. Subclinical hypothyroidism may be associated with elevated highsensitive c-reactive protein (low grade inflammation) and fasting hyperinsulinemia. Endocrine Journal,2005,52 (1):89-94
[197]Hueston WJ, King DE, Geesey ME. Serum biomarkers for cardiovascular inflammation in subclinical hypothyroidism. Clinical Endocrinology,2005,63 (5):582-587
[198]Luboshitzky R, Herer P. Cardiovascular risk factors in middle-aged women with subclinical hypothyroidism. Neuropean Endocrinology Letters,2004,25 (4):262-266
[199]Homoncik M, Gessl A, Ferlitsch A, Jilma B, Vierhapper H. Altered platelet plug formation in hyperthyroidism and hypothyroidism. The Journal of Clinical Endocrinology and Metabolism,2007,92 (8): 3006-3012
[200]Canturk Z, Cetinarslan B, Tarkun I, Canturk NZ, Ozden M, Duman C. Hemostatic system as a risk factor for cardiovascular disease in women with subclinical hypothyroidism. Thyroid,2003,13 (10):971-977
[201]Muller B, Taskiris DA, Roth CB, Guglielmetti M, Staub JJ, Marbet GA. Haemostatic profile in hypothyroidism as potential risk factor for vascular or thrombotic disease. European Journal of Clinical Investigation,2001,31 (2):131-137
[202]Folsom AR, Wu KK, Rasmussen M, Chambless LE, Aleksic N, Nieto FJ. Determinants of population changes in fibrinogen and factor Ⅶ over 6 years:the Atherosclerosis Risk in Communties (ARIC) Study. Arteriosclerosis, Thrombosis, and Vascular Biology,2000,20 (2):601-606
[203]Imaizumi M, Akahoshi M, Ichimaru S, Nakashima E, Hida A, Soda M, Usa T, Ashizawa K, Yokoyama N, Maeda R, Nagataki S, Eguchi K. Risk for ischemic heart disease and all-cause mortality in subclinical hypothyroidism. The Journal of Clinical Endocrinology and Metabolism,2004,89 (7):3365-3370
[204]Davis JD, Tremont G. Neuropsychiatric aspects of hypothyroidism and treatment reversibility. Minerva Endocrinologica,2007,32 (1):49-65
[205]Pollock MA, Sturrock A, Marshall K, Davidson KM, Kelly CJ, McMahon AD, McKaren EH. Thyroxine treatment in patients with symptoms of hypothyroidism but thyroid function tests within the reference range: randomised double blind placebo controlled crossover trial. British Medical Journal,2001,323 (7318): 891-895
[206]McDermott MT, Ridgway EC. Subclinical hypothyroidism is mild thyroid failure and should be treated. The Journal of Clinical Endocrinology and Metabolism,2001,86 (10):4585-4590
[207]Fatourechi V. Subclinical hypothyroidism:an update for primary care physicians. Mayo Clinic Proceedings, 2009,84(1):65-71
[2]Reaven GM. Banting Lecture 1988:Role of insulin resistance in human disease. Diabetes,1988,37 (12): 1595-1607
[3]Klein I. Thyroid hormone and the cardiovascular system. The American Journal of Medicine,1990,88 (6): 631-637
[4]Boelaert K, Franklyn JA. Thyroid hormone in health and disease. The Journal of Endocrinolgy,2005,187 (1): 1-5
[5]Duntas LH, Wartofsky L. Cardiovascular risk and subclinical hypothyroidism:focus on lipids and new emerging risk factors. What is the evidence? Thyroid,2007,17 (11):1075-1084
[6]Bell RJ, Rivera-Woll L, Davison SL, Topliss DJ, Donath S, Davis SR. Well-being, health-related quality of life and cardiovascular disease risk profile in women with subclinical thyroid disease-a community-based study. Clinical Endocrinology,2007,66 (4):548-556.
[7]Uzunlulu M, Yorulmaz E, Oguz A. Prevalence of subclinical hypothyroidism in patients with metabolic syndrome. Endocrinology Journal,2007,54 (1):71-76
[8]Klein I, Ojamaa K. Thyroid hormone and the cardiovascular system. The New England Journal of Medicine, 2001,344 (7):501-509
[9]Klein I, Ojamaa K.Thyrotoxicosis and the heart. Endocrinology and Metabolism Clinics of North America, 1998,27(1):51-62
[10]Cooper D, Halpern R, Wood LC, Lavin AA, Ridgway EC. L-thyroxine therapy in subclinical hypothyroidism:a double-blind, placebo-controlled trial. Annals of Internal Medicine,1984,101 (1):18-24
[11]Bakker SJ, TerMaaten JC, Popp-Snijders C, Slaets JP, Heine RJ, Gans RO. The relationship between thyrotropin and low density lipoprotein cholesterol is modified by insulin sensitivity in healthy euthyroid subjects. The Journal of Clinical Endocrinology and Metabolism,2001,86 (3):1206-1211
[12]Surks MI, Ortiz E, Daniels GH, Sawin CT, Col NF, Cobin RH, Franklyn JA, Hershman JM, Burman KD, Denke MA, Gorman C, Cooper RS, Weissman NJ. Subclinical thyroid disease:scientific review and guidelines for diagnosis and management. The Journal of Amerian Medical Association,2004,291 (2): 228-238
[13]单忠艳,滕卫平,李玉妹,王占乙,金迎,关海霞,滕晓春,杨帆,高天舒,王微波,史晓光,佟雅洁,陈威.碘致甲状腺功能减退症的流行病学对比研究.中华内分泌代谢杂志,2001,17(2)：71-74
[14]杨帆,滕卫平,单忠艳,王占乙,金迎,关海霞,胡凤楠,滕晓春,高天舒,王微波,史晓光,佟雅洁,陈威,杨世明,崔炳元.不同碘摄入量地区甲亢的对比流行病学研究.中华内分泌代谢杂志,2001,17(4)：197-201
[15]关海霞,滕卫平,杨世明,崔炳元,单忠艳,金迎,滕晓春,杨帆,高天舒,王微波,史晓光,佟雅洁.
不同碘摄入量地区甲状腺癌的流行病学研究.中华医学杂志,2001,81(8)：457-458
[16]王微波,金迎,滕卫平,单忠艳,李玉姝,高天舒,关海霞,杨帆,滕晓春,史晓光,佟雅洁,陈威,滕笛.不同碘摄入量地区正常人群血清TSH水平的流行病学对比研究.中华内分泌代谢杂志,2002,18(5)：355-356
[17]佟雅洁,滕卫平,金迎,李玉姝,关海霞,王微波,高天舒,滕晓春,杨帆,史晓光,陈威,满娜,李智,国秀娟.不同碘摄入量地区硒与甲状腺功能关系的流行病学研究.中华医学杂志,2003,83(23)：2036-2039
[18]滕晓春,滕笛,单忠艳,关海霞,李玉姝,于晓会,范晨玲,崇巍,杨帆,何力,刘华,温松臣,戴红,毛金媛,谷晓岚,于扬,李佳,陈彦彦,赵冬,杨榕,姜雅秋,李晨阳,滕卫平.碘摄入量增加对甲状腺疾病影响的五年前瞻性流行病学研究.中华内分泌代谢杂志,2006,22(6)：512-517
[19]杨帆,李佳,单忠艳,滕晓春,滕笛,关海霞,李玉姝,崇巍,于晓会,范晨玲,戴红,于扬,毛金媛,何力,陈彦彦,赵冬,滕卫平.不同碘摄入量社区甲状腺功能亢进症的五年流行病学随访研究.中华内分泌代谢杂志,2006,22(6)：518-522
[20]杨帆,李佳,单忠艳,滕晓春,滕笛,关海霞,李玉姝,崇巍,于晓会,范晨玲,戴红,于扬,毛金媛,何力,陈彦彦,赵冬,滕卫平.不同碘摄入量社区甲状腺功能亢进症的五年流行病学随访研究.中华内分泌代谢杂志,2006,22(6)：523-527
[21]戴红,单忠艳,滕晓春,滕笛,关海霞,李玉姝,于晓会,范晨玲,崇巍,杨帆,刘华,温松臣,谷晓岚,毛金媛,于扬,李佳,陈彦彦,赵冬,杨榕,姜雅秋,滕卫平.不同碘摄入量社区甲状腺功能减退症的五年随访研究.中华内分泌代谢杂志,2006,22(6)：528-531
[22]Yang F, Teng W, Shan Z, Guan H, Li Y, Jin Y, Hu F, Shi X, Tong Y, Chen W, Yuan B, Wang Z, Cui B, Yang S. Epidemiological survey on the relationship between different iodine intakes and the prevalence of hyperthyroidism. European Journal of Endocrinology,2002,146 (5):613-618
[23]Shan ZY, Li YS, Wang ZY, Jin Y, Guan HX, Hu FN, Teng XC, Yang F, Gao TS, Wang WB, Shi XG, Tong YJ, Chen W, Teng WP. Effect of different iodine intake on the prevalence of hypothyroidism in 3 counties in China. Chinese Medical Journal (English).2005,20,118 (22):1918-1920
[24]Teng W, Shan Z, Teng X, Guan H, Li Y, Teng D, Jin Y, Yu X, Fan C, Chong W, Yang F, Dai H, Yu Y, Li J, Chen Y, Zhao D, Shi X, Hu F, Mao J, Gu X, Yang R, Tong Y, Wang W, Gao T, Li C. Effect of iodine intake on thyroid diseases in China. The New England Journal of Medicine,2006,354 (26):2783-2793
[25]张志利,彭国英,李树堂.太原地区健康体检人群甲状腺功能紊乱患病情况调查.中华内分泌代谢杂志,2002,18(6)：446-448
[26]赵媛,施秉银,都珍玲,徐莉,赵新,范庆利,樊新华,王淑梅,杨建辉,许春云,龚益.2056例成人甲状腺功能及其自身抗体分析.中华内分泌代谢杂志,2004,20(6)：490-492
[27]Ross DS. Serum thyroid-stimulating hormone measurement for assessment of thyroid function and disease. Endocrinology ans Metabolism Clinics of North America,2001,30 (2):245-264
[28]国务院人口普查办公室,国家统计局人口和社会科技统计司.中国2000年人口普查资料.北京：中国统计出版社,2002：570-572
[29]Klein I, Danzi S. Thyroid disease and the heart. Circulation,2007,116 (15):1725-1735
[30]Golden SH, Robinson KA, Saldanha I, Anton B, Ladenson PW. Clinical review:Prevalence and incidence of endocrine and metabolic disorders in the United States:a comprehensive review. The Journal of Clinical Endocrinology and Metabolism,2009,94 (6):1853-1878
[31]Tunbridge WM, Evered DC, Hall R, Appleton D, Brewise M, Clark F, Evans JG, Young E, Bird T, Smith PA. The spectrum of thyroid disease in a community:the Whickham Survey. Clinical Endocrinology,1977,7 (6): 481-493
[32]Hollowell JG, Staehling NW, FlanderWD, Hannon WH, Gunter EW, Spencer CA, Braverman LE. Serum TSH, T4, and thyroid antibodies in the United States population (1988 to 1994):Nation Health and Nutrition Examination Survey (NHANES III). Journal of Clinical Endocrinology and Metabolism,2002,87 (2): 489-499
[33]Canaris GJ, Manowitz NR, Mayor G, Ridgway EC. The Colorado thyroid disease prevalence study. Archives of Internal Medicine,2000,160 (4):526-534
[34]Knudsen N, Jorgensen T, Rasmussen S, Christiansen E, Perrild H. The prevalence of thyroid dysfunction in a population with borderline iodine deficiency. Clinical Endocrinology,1999,51 (3):361-367
[35]Laurberg P, Pedersen KM, Hreidarsson A, Sigfusson N, Iversen E, Knudsen PR. Iodine intake and the pattern of thyroid disorders:a comparative epidemiological study of thyroid abnormalities in the elderly in Iceland and in Jutland, Denmark. The Journal of Clinical Endocrinology and Metabolism,1998,83 (3): 765-769
[36]Vejbjerg P, Knudsen N, Perrild H, Laurberg P, Carle A, Pedersen IB, Rasmussen LB, Ovesen L, Jorgensen T. Lower prevalence of mild hyperthyroidism related to a higher iodine intake in the population:prospective study of a mandatory iodization programme. Clinical Endocrinology,2009,71 (3):440-445
[37]彭雯,王晓东,刘超.碘摄入量与自身免疫性甲状腺疾病关系的研究进展.医学综述,2008,14(16)：522-525
[38]黄学敏,朱文明,姚顺荣,周金水,屠兴国,陈颖.1995-200年浙江省碘缺乏病监测10年结果分析.中国地方病学杂志,2006,25(3)：665-667
[39]Slowinska-Klencka D, KlenckiM, Sporny S, Lewinski A. Fine-needle aspiration biopsy of the thyroid in an area of endemic goitre:influence of restored sufficient iodine supp lementation on the clinical significance of cytological results. European Journal of Endocrinology,2002,146 (1):19-26
[40]Zois C, Stavrou L, Kalogera C, Svarna E, Dimoliatis I, Seferiadis K, Tsatsoulis A. High prevalence of autoimmune thyroiditis in schoolchildren after elimination of iodine deficiency in northwestern Greece. Thyroid,2003,13 (5):485-489
[41]李玉姝,赵冬,单忠艳,滕晓春,滕笛,关海霞,于晓会,范晨玲,崇巍,杨帆,戴红,谷晓岚,于扬,毛金媛,李佳,陈彦彦,杨榕,姜雅秋,李晨阳,滕卫平.不同碘摄入量地区甲状腺自身抗体的流行病学五年随访研究.中华内分泌代谢杂志,2006,22(6)：518-522
[42]Roti E, Uberti ED. Iodine excess and hyperthyroidism.. Thyroid,2001,11 (5):493-500
[43]Markou K, GeorgopoulosN, Kyriazopoulou V, Vagenakis AG. Iodine-induced hypothyroidism. Thyroid, 2001,11 (5):501-510
[44]Weetman AP. Autoimmune thyroid disease:propagation and progression. European Journal of Endocrinology,2003,148 (1):1-9
[45]Ross DS, Daniels GH, Gouveia D. The use and limitations of a chemiluminescent thyrotropin assay as a single thyroid function test in an out-patient endocrine clinic. The Journal of Clinical Endocrinology and Metabolism,1990,71 (3):764-769
[46]Kasagi K, Takahashi N, Inoue G, Honda T, Kawachi Y, Izumi Y. Thyroid function in Japanese adults as assessed by a general health checkup system in relation with thyroid-related antibodies and other clinical parameters. Thyroid,2009,19 (9):937-944
[47]Biondi B, Palmieri EA, Klain M, Schlumberger M, Filetti S, Lombardi G. Subclinical hyperthyroidism: clinical features and treatment options. European Journal of Endocrinology,2005,152 (1):1-9
[48]Fatourechi V, Laukarani M, Schryver PG, Vanness DJ, Long KH, Klee GG. Factors influencing clinical decisions to initiate thyroxine therapy for patients with mildly increased serum thyrotropin (5.1-10.0 mU/L). Mayo Clinical Proceedings,2003,78 (5):554-560
[49]Meier C, Staub JJ, Roth CB, Guglielmetti M, Kunz M, Miserez AR, Drewe J, Huber P, Herzog R, Muller B. TSH-controlled L-thyroxine therapy reduces cholexterol levels and clinical symptoms in subclinical hypothyroidism;a double blind, placebo-controlled trail (basd thyroid study). The Journal of Clinical Endocrinology and Metabolism,2001,86 (10):4860-4866
[50]Fatourechi V. Subclinical thyroid disease. Mayo Clinical Proceedings,2001,76 (4):413-416
[51]Danese MD, Ladenson PW, Meinert CL, Powe NR. Clinical review:effect of thyroxine therapy on serum lipoproteins in patients with mild thyroid failure:a quantitative review of the literature. The Journal of Clinical Endocrinology and Metabolism,2000,85 (9):2993-3001
[52]Franklyn JA, Sheppard MC, Maisonneuve P. Thyroid function and mortality in patients treated for hyperthyroidism. The Journal of American Medical Association,2005,294 (1):71-80
[53]Diez JJ, Iglesias P. Spontaneous subclinical hypothyroidism in patients older than 55 years:an analysis of natural course and risk factors for the development of overt thyroid failure. The Jouranl of Clinical Endocrinology and Metabolism,2004,89 (10):4890-4897
[54]Biondi B, Palmieri EA, Lombardi G, Fazio S. Effects of subclinical thyroid dysfunction on the heart. Annals of Internal Medicine,2002,137 (11):904-914
[55]Arrigo T, Wasniewska M, Crisafulli G, Lombardo F, Messina MF, Rulli I, Salzano G, Valenzise M, Zirilli G, De Luca F. Subclinical hypothyroidism:the state of the art. Journal of Endocrinological Investigation,2008, 31(1):79-84
[56]Estaquio C, Valeix P, Leenhardt L, Modigliani E, Boutron-Ruault MC, Cherie-Challine L, Legrand M, Hercberg S, Castetbon K. Serum thyrotropin and free thyroxine reference ranges as defined in a disease-free sample of French middle-aged adults. Clinical Chemistry and Laboratory Medicine.2009,47 (12):
1497-1505
[57]Takeda K, Mishiba M, Sugiura H, Nakajima A, Kohama M, Hiramatsu S. Evaluated reference intervals for serum free thyroxine and thyrotropin using the conventional outliner rejection test without regard to presence of thyroid antibodies and prevalence of thyroid dysfunction in Japanese subjects. Endocrine Journal,2009,56 (9):1059-1066
[58]Morganti S, Ceda GP, Saccani M, Milli B, Uqolotti D, Prampolini R, Maqqio M, Valenti G, Ceresini G. Thyroid disease in the elderly:sex-related differences in clinical expression. Journal of Endocrinological Investigation,2005,28 (11):101-104
[59]Rehman SU, Cope DW, Senseney AD, Brzezinski W. Thyroid disorders in elderly patients. Southern Medical Journal,2005,98 (5):543-549
[60]Diez JJ, Molina I, Ibars MT. Prevalence of thyroid dysfunction in adults over age 60 years from an urban community. Experimental and Clinical Endocrinology and Diabetes,2003,111 (8):480-485
[61]Boelaert K, Franklyn JA. Thyroid hormone in health and disease. The Journal of Endocrinology,2005,187 (1):1-15
[62]Cappola AR, Fried LP, Arnold AM, Danese MD, Kuller LH, Burke GL, Tracy RP, Ladenson PW. Thyroid status, cardiovascular risk, and mortality in older adult. JAMA,2006,295 (6):1033-1041
[63]Smit JW, Eustatia-Rutten CF, Corssmit EP, Pereira AM, Frolich M, Bleeker GB, Holman ER, van der Wall EE, Romijn JA, Bax JJ. Reversible diastolic dysfunction after long-term exogenous subclinical hyperthyroidism:a randomized, placebo-controlled study. The Journal of Clinical Endocrinology and Metabolism,2005,90 (12):6041-6047
[64]Sheppard MC, Holder R, Franklyn JA. Levothyroxine treatment and occurrence of fracture of the hip. Archives of Internal Medicine,2002,162 (2):338-343
[65]Peeters RP. Thyroid hormones and aging. Hormones,2008,7(1):28-35
[66]Hadj-Kacem H, Rebuffat S, Mnif-Feki M, Belguith-Maalej S, Ayadi H, Peraldi-Roux S. Autoimmune thyroid diseases:genetic susceptibility of thyroid-specific genes and thyroid autoantigens contributions. International Journal of Immunogenetics,2009,36 (2):85-96
[67]Monzani F, Dibello V, Caraccio N, Bertini A, Giorgi D, Giusti C, Ferrannini E. Effect of levothyroxine on cardiac function and stucture. The Journal of Clinical Endocrinology and Metabolism,2001,86 (3): 1110-1115
[68]Biondi B, Fazio S, Palmieri EA, Carella C, Panza N, Cittadini A, Bone F, Lombardi G, Sacca L. Left ventricular diastolic dysfunction in patients with Subclinical hypothyroidism. The Journal of Clinical Endocrinology and Metabolism,1999,84 (6):2064-2067
[69]Hak AE, Pols HA, Visser TJ, Drexhage HA, Hofman A, Witteman JC. Subclinical hypothytoidism is an independent risk factor for athersclerosis and myocardial infarction in elderly women:the Rotterdam Study. Annals of Internal Medicine,2000,132 (4):270-278
[70]Auer J, Berent R, Weber T, Lassnig E, Eber B. Thyroid function is associated with presence and severity of coronary atherosclerosis. Clinical Cardiology,2003,26 (12):569-573
[71]Taddei S, Caraccio N, Virdis A, Dardano A, Versari D, Ghiadoni L, Salvetti A, Ferrannini E, Monzani F. Impaired endothelium-dependent vasodilatation in subclinical hypothyroidism:beneficial effect of levothyroxine therapy. The Journal of Clinical Endocrinology and Metabolism,2003,88 (8):3731-3737
[72]Parle JV, Maisonneuve P, Sheppard MC, Boyle P, Franklyn JA. Prediction of all cause and cardiovascular mortality in elderly people from one low serum thyrotropin result:a 10-year cohort study. The Lancet,2001, 358 (9285):861-865
[73]Milionis HJ, Efstathiadou Z, Tselepis AD, Bairaktari ET, Tsironis LD, Tsatsoulis A, Elisaf MS. Lipoprotein(a) levels and apolipoprotein(a) isoform size in patients with subclinical hypothyroidism:effect of treatment with levothyroxine. Thyroid,2003,13 (4):365-369
[74]Vanderpump MP, Tunbridge WM, French JM, Appleton D, Bates D, Clark F, Grimley Evans J, Hasan DM, Rodgers H, Tunbridge F. The incidence of thyroid disorders in the community:a twenty-year follow-up of the Whickham Survey. Clinical Endocrinology,1995,43 (1):55-68.
[75]Williams CM. Using medications appropriately in older adults. American Family Physician,2002,66 (10): 1917-1924
[76]Zimmet P, Magliano D, Matsuzawa Y, Alberti G, Shaw J. The metabolic syndrome:a global public health problem and a new definition. Journal of Atherosclerosis and Thrombosis,2005,12 (6):295-300
[77]朱禧星.胰岛素抵抗,代谢综合征与胰岛素增敏剂.中华内分泌代谢杂志,2000,16(6)：333-334
[78]Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1:diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabetic Medicine,1998,15 (7):539-553
[79]Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, Taskinen MR, Groop L. Cardiovascular morbidity and mortality associated with the metabolic Syndrome. Diabetes Care,2001,24 (4):683-689
[80]Trevisan M, Liu J, Bahsas FB, Menotti A. Syndrome X and mortality:a population-based study. American Journal of Epidemiology,1998,148 (10):958-966
[81]National Cholesterol Education Program (NCEP):Expert Panel on Detection and Treatment of High Blood Cholesterol in Adults. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel Ⅲ) final report. Circulation,2002,106 (25):3143-3421
[82]Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, Spertus JA, Costa F; American Heart Association; National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome:an American Heart Association/National Heart, Lung and Blood Institute scientific statement. Circulation,2005,112(17):2735-2752
[83]中华医学会糖尿病分会关于代谢综合征研究协作组.中华医学会糖尿病分会关于代谢综合征的建议.中华糖尿病杂志,2004,12(3)：156-161
[84]Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults. The Journal of American Medical Association,2002,287 (3):356-359
[85]Ervin RB. Prevalence of metabolic syndrome among adults 20 years of age and over, by sex, age, race and ethnicity, and body mass index:United States,2003-2006. National Health Statistics Reports,2009,5 (13): 1-7
[86]Huang PL. A comprehensive definition for metabolic syndrome. Disease Models and Mechanism,2009,2 (5-6):231-237
[87]张毅,李玲,厉平,王贵新.不同代谢综合征诊断标准在沈阳地区人群中的比较.中国医科大学学报,2007,36(2)：86-87
[88]李济宾,古萍,张晋昕,张熙,陈彩霞,王勃维,洪令瑶,李娟,雷迪,李明凤.代谢综合征三种诊断标准在广东省人群中的应用对比.中国健康教育,2008,24(2)：113-116
[89]刘庆敏,施世锋,施文英,李莉,陈仁华,裘欣,张楚,方顺源,金达丰.杭州市成人代谢综合征及其各组分患病率分析.中国预防医学杂志,2008,9(1)：18-21
[90]罗不凡,杜琳,潘冰莹,陈健,徐健敏,王建华.广州市1 5岁以上居民代谢综合征流行特征分析.中国糖尿病杂志,2008,16(5)：267-270
[91]邵继红,王坤,沈霞,李东野,李翔,方晓芬,何庆峰,刘微微,任香梅,张美荣,金英良.徐州市居民代谢综合征患病率调查.中国公共卫生,2008,24(9)：1118-1119
[92]吴元民,邵宝蓉,顾惠琳,袁杏生,刘绍芳,贾伟平,项坤三.上海市华阳社区糖尿病、高血压、血脂紊乱及代谢综合征基线调查.上海医学,2001,24(4)：195-198
[93]姜素英,章晖,左玉华,刘兰花,原永明,方蓉,蔡伟青,贾伟平,项坤三.上海市曹杨社区20岁以上人群代谢综合征及其相关疾病的流行病学调查.上海医学,2003,26(1)：3-6
[94]冯波,李栩,黄亦文,乐秀康,富明,陈明慧,戴明德,倪亚芳,赵竹芳,周凤英,孟仲莹,王惠玲,姚国良,张容,刘昊,张小倩.上海市浦东新区社区人群代谢综合征状况和相关危险因素分析.中华内分泌代谢杂志,2004,20(3)：231-232
[95]Park YW, Zhu S, Palaniappan L, Heshka S, Carnethon MR, Heymsfield SB. The metabolic syndrome: Prevalence and associated risk factor findings in the US population from the third national health and nutrition examination survey. Archives of Internal Medicine,2003,163 (4):427-436
[96]Kahn R, Buse J, Ferrannini E, Stern M; American Diabetes Association; European Association for the Study of Diabetes. The metabolic syndrome:time for a critical appraisal:joint statement from the American Diabetes Association and the European Association for the study of diabetes. Diabetes Care,2005,28 (9):2289-2304
[97]顾东风,Reynolds K,杨文杰,陈恕凤,吴锡桂,段秀芳,蒲晓东,徐丽华,吴先萍,陈祥福,魏仁敏,陈娜萦,吴天一,王礼桂,姚才良,牟建军,马义峰,王晓飞,Whelton P,何江.中国成年人代谢综合征的患病率.中华糖尿病杂志,2005,13(3)：181-186
[98]脑卒中、冠心病发病危险因素进一步研究协作组.11省市队列人群代谢综合征的流行病学研究.中华预防医学杂志,2002,36(5)：298-300
[99]任振勇,黄磊,庞星火,贾娜.北京市成人代谢综合征及其影响因素分析.中国公共卫生,2005,21(8)： 981-921
[100]卢伟,刘美霞,李锐,傅华,金泰廙,张胜年.上海15-74岁居民代谢综合征的流行特征.中华预防医学杂志,2006,40(4)：262-268
[101]Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, Bonadonna RC, Muggeo M; Bruneck study. Carotid atherosclerosis and coronary heart disease in the metabolic syndrome:prospective data from the Bruneck Study. Diabetes Care,2003,26 (4):1251-1257
[102]Grundy SM, Hansen B, Smith SC Jr, Kahn RA; American Heart Association; National Heart, Lung, and Blood Institute; American Diabetes Association. Definition of metabolic syndrome:report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation,2004,109 (3):433-438
[103]Ninomiya JK, L'Italien G, Criqui MH, Whyle JL, Gamst A, Chen RS. Association of the metabolic syndrome with history of myocardial infarction and stroke in the third national health and nutrition examination survey. Circulation,2004,109 (1):42-46
[104]Klein BE, Klein R, Lee KE. Components of the metabolic syndrome and risk of cardiovascular disease and diabetes in beaver dam. Diabetes Care,2002,25 (10):1790-1794
[105]Deedwania PC. Metabolic syndrome and vascular disease:is nature or nature leading the new epidemic of cardiovascular disease? Circulation,2004,109 (1):2-4
[106]Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, Taskinen MR, Groop L. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care,2001,24 (4):683-689
[107]Resnick HE, Jones K, Ruototo G, Jain AK, Henderson J, Lu W, Howard BV; Strong Heart Study. Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease in nondiabetic American Indians:the Strong Heart Study. Diabetes Care,2003,26 (3):861-867
[108]Carr MC, Brunzell JD. Abdominal obesity and dyslipidemia in the metabolic syndrome:importance of type 2 diabetes and familial combined hyperlipidemia in coronary artery disease risk. The Journal of Clinical Endocrinology and Metabolism,2004,89 (6):2601-2607
[109]Anand SS, Yi Q, Gerstein H, Lonn E, Jacobs R, Vuksan V, Teo K, Davis B, Montague P, Yusuf S; Study of Health Assessment and Risk in Ethnic Groups; Study of Health Assessment and Risk Evaluation in Aboriginal Peoples Investigators. Relationship of metabolic syndrome and fibrinolytic dysfunction to cardiovascular disease. Circulation,2003,108 (4):420-425
[110]Grundy SM, Hansen B, Smith SC Jr, Cleeman JI, Kahn RA; American Heart Association; National Heart, Lung, and Blood Institute; American Diabetes Association. Clinical management of metabolic syndrome: report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management. Circulation,2004,109 (4):551-556
[111]Alberti KG, Zimmet P, Shaw J. The metabolic syndrome-a new worldwide definition. The Lancet,2005, 366(9491):1059-1062
[112]Boden G. Effect s of free fatty acids (FFA) on glucose metabolism:significance for insulin resistance and type 2 diabetes. Experimental and Clinical Endocrinology and Diabetes,2003,111 (3):121-124
[113]Chien KL, Hsu HC, Sung FC, Su TC, Chen MF, Lee YT. Metabolic syndrome as a risk factor for coronary heart disease and stroke:an 11-year prospective cohort in Taiwan community. Atherosclerosis,2007,194 (1):214-221
[114]Wang J, Ruotsalainen S, Moilanen L, Lepisto P, Laakso M, Kuusisto J. The metabolic syndrome predicts cardiovascular mortality:a 13-year follow-up study in elderly nondiabetes Finns. European Heart Journal, 2007,28 (7):857-864
[115]Simons LA, Simons J, Friedlander Y, McCallum J. Does a diagnosis of the metabolic syndrome provide additional prediction of cardiovascular disease and total mortality in the elderly? The Dubbo Study. The Medical Journal of Australia,2007,186 (8):400-403
[116]Danzi S, Klein I. Thyroid hormone and blood pressure regulation. Current Hypertension Reports,2003,5 (6):523-520
[117]Duntas LH. Thyroid disease and lipids. Thyroid,2002,12 (4):287-293
[118]Fommei E, Iervasi G. The role of thyroid hormone in blood pressure homeostasis:evidence from short-term hypothyroidism in humans. The Journal of Clinincal Endocrinology and Metabolism,2002,87 (5):1996-2000
[119]Cappola AR, Ladenson PW. Hypothyroidism and atherosclerosis. Journal of Clinical Endocrinology and Metabolism,2003,88 (6):2438-2444
[120]Takashima N, Niwa Y, Mannami T, Tomoike H, Iwai N. Characterization of subclinical thyroid dysfunction from cardiovascular and metabolic viewpoints:The Suita Study. Circulation Journal,2007,71 (2):191-195
[121]Jung CH, Sung KC, Shin HS, Rhee EJ, Lee WY, Kim BS, Kang JH, Kim H, Kim SW, Lee MH, Park JR, Kim SW. Thyroid dysfunction and their relation to cardiovascular risk factors such as lipid profile, hsCRP, and waist hip ratio in Korea. Korean Journal of Internal Medicine,2003,18 (3):146-153
[122]Teixeira PF, Reuters VS, Ferreira MM, Almeida CP, Reis FA, Melo BA, Buescu A, Costa AJ, Vaisman M. Treatment of subclinical hypothyroidism reduces atherogenic lipid levels in a placebo-controlled double-blind clinical trial. Hormone and Metabolic Research,2008,40 (1):50-55
[123]BindelsAJ, Westendorp RG, FrolichM, Seidell JC, Blokstra A, Smelt AH. The prevalence of subclinical hypothyroidism at different total plasma cholesterol levels in middle men and women:a need for case-finding. Clinical Endocrinology,1999,50 (2):217-220
[124]Samuels MH. Subclinical thyroid disease in the elderly. Thyroid,1998,8 (9):803-813
[125]Biondi B, Cooper DS. The clinical significance of subclinical thyroid dysfunction. Endocrine Reviews, 2008,29(1):76-131
[126]Takashima N, Niwa Y, Mannami T, Tomoike H, Iwai N. Characterization of subclinical thyroid dysfunction from cardiovascular and metabolic viewpoints:the Suita study. Circulation Journal,2007,71 (2): 191-195
[127]Knudsen N, Laurberg P, Rasmussen LB, Bulow I, Perrild H, Ovesen L, Jorgensen T. Small differences in thyroid function may be important for body mass index and the occurrence of obesity in the population. The Journal of Clinical Endocrinology and Metabolism,2005,90 (7):4019-4024
[128]Nyrnes A, Jorde R, Sundsfjord J. Serum TSH is positively associated with BMI. International Journal of Obesity,2006,30 (1):100-105
[129]Shon HS, Jung ED, Kim SH, Lee JH. Free T4 is negatively correlated with body mass index in euthyroid women. Korean Journal of Internal Medicine,2008,23 (2):53-57
[130]Michalaki MA, Vagenakis AG, Leonardou AS, Argentou MN, Habeos IG, Makri MG, Psyrogiannis AI, Kalfarentzos FE, Kyriazopoulou VE. Thyroid function in humans with morbid obesity. Thyroid,2006,16(1): 73-78
[131]Manji N, Boelaert K, Sheppard MC, Holder RL, Gough SC, Franklyn JA. Lack of association between serum TSH or free T4 and body mass index in euthyroid subjects. Clinical Endocrinology,2006,64 (2): 125-128
[132]Isozaki O, Tsushima T, Nozoe Y, Miyakawa M, Takano K. Leptin regulation of the thyroids:negative regulation on thyroid hormone levels in euthyroid subjects and inhibitory effects on iodide up take and Na+/I-symporter mRNA expression in rat FRTL-5 cells. Endocrine Journal,2004,51(4):415-423
[133]Cabanelas A, Lisboa PC, Moura EG, Pazos-Moura CC. Acute effects of leptin on 5'-deiodinases are modulated by thyroid state of fed rats. Hormone and Metabolic Research,2007,39 (11),818-822
[134]Dernellis J, Panaretou M. Effects of thyroid replacement therapy on arterial blood pressure in patients with hypertension and hypothyroidism. American Heart Journal,2002,143 (4):718-724
[135]Walsh JP, Bremner AP, Bulsara MK. Subclinical thyroid dysfunction and blood pressure:a community2based study. Clinical Endocrinology,2006,65 (4):486-491
[136]Duan Y, Peng W, Wang X, Tang W, Liu X, Xu S, Mao X, Feng S, Feng Y, Qin Y, Xu K, Liu C, Liu C. Community-based study of the association of subclinical thyroid dysfunction with blood pressure. Endoucrine,2009,35 (2):136-142
[137]Asvold BO, Bj(?)ro T, Nilsen TI, Vatten LJ. Association between blood pressure and serum thyroid-stimulating hormone concentration within the reference range:a population-based study. The Journal of Clinical Endocrinology and Metabolism,2007,92 (3):841-845
[138]毛玉山,周丽诺,李福军,叶红英,杜娟,施淑钧,陈长喜,申定国,黄童,洪中立.中老年高尿酸血症对血管内皮功能的影响.中华风湿病学杂志,2006,10(3)：169-171
[139]See LC, Kuo CF, Chuang FH, Li HY, Chen YM, Chen HW, Yu KH. Serum uric acid is independently associated with metabolic syndrome in subjects with and without a low estimated glomerular filtration rate. The Journal of Rheumatology,2009,36 (8):1691-1698
[140]Giordano N, Santacroce C, Mattii G, Geraci S, Amendola A, Gennari C. Hyperuricemia and gout in thyroid endocrine disorders. Clinical and Experimental Rheumatology,2001,19 (6):661-665
[141]蒋明,Yu D,林孝义.中华风湿病学.北京：华夏出版社,2004,1215-1227
[142]Kuzzel WC, Schaffarzick RW, Naugler WE. Some observations on 520 gouty patients. The Journal of Chronic Disease,1955,2 (1):64-68
[143]Sato A, Shirota T, Shinoda T, Komiya I, Aizawa T, Takemura Y, Yamada T. Hyperuricemia in patients with hyperthyoidism due to Graves' disease. Metabolism,1995,44 (2):207-211
[144]Boyle JA, Greig WR, Duncan AM, Boyle IT, Buchanan WW. Serum uric acid values in various states of thyroid function. Acta Rheumatologic Scandinavica,1966,12 (3):204-209
[145]Mikkelsen WM, Dodge HJ, Valkenburg H. The distribution of serum uric acid values in a population unselectde as to gout or hyperuricemia. The American Journal of Medicine,1965,39 (2):242-251
[146]毛玉山,周丽诺,叶红英,黄童,陈长喜,杜娟,洪中立,胡仁明.宁波市某石化企业员工高尿酸血症和痛风患病率调查.中华内分泌代谢杂志,2006,22(8)：338-341
[147]Ford HC, Lim WC, Chisnall WN, Pearce JM. Renal function and electrolyte levels in hyperthyroidism: urinary protein excretion and the plasma concentration of urea, creatinine, uric acid, hydrogen ion and electrolytes. Clinical Endocrinology,1989,30 (3):293-301
[148]Shirota T, Shinoda T, Yamada T, Aizawa T. Alteration of renal function in hyperthyroism:increased tubular secretion of creatinie and decreased distal tubule delivery of chloride. Metabolism,1992,41 (4):402-405
[149]Kutzing MK, Firestein BL. Altered uric acid levels and disease states. The Journal of Pharmacology and Experimental Therapeutics,2008,324 (1):1-7
[150]石恩荣.高尿酸血症与高血压关系的探讨.右江民族医学院学报,2006,28(1)：37-38
[151]朱君,徐俊文.高尿酸血症和痛风的流行病学及其危险因素的研究进展.现代生物医学进展,2008,8(1)：191-195
[152]Bo S, Cavallo-Perin P, Gentile L, Repetti E, Pagano G. Hypouricemia and hyperuricemia in type 2 diabetes: two different phenotypes. European Journal of Clinical Investigation,2001,31 (4):318-321
[153]Oyama C, Takahashi T, Oyamada M, Oyamada T, Ohno T, Miyashita M, Saito S, Komatsu K, Takashina K, Takada G Serum uric acid as an obesity-related indicator in early adolescence. The Tohoku Journal of Experimental Medicine,2006,209 (3):257-262
[154]Puig JG, Martinez MA. Hyperuricemia, gout and the metabolic syndrome. Currernt Opinion in Rheumatology,2008,20 (2):187-191
[155]Mooraki A, Bastani B. Reversible renal insufficiency, hyperuricemia and gouty arthritis in a case of hypothyroidism. Clinical Nephrology,1998,49 (1):59-61
[156]Bonetti PO, Lerman LO, Lerman A. Endothelial dysfunction:a marker of atherosclerotic risk. Arteriosclerosis, Thrombosis, and Vasculai Biology,2003,23 (2):168-175
[157]Biondi B, Galderisi M, Pagano L, Sidiropulos M, Pulcrano M, D' Errico A, Ippolito S, Rossi A, de Divitiis O, Lombardi G. Endothelial-mediated coronary flow reserve in patients with mild thyroid hormone deficiency. European Journal of Endocrinology,2009,161 (2):323-329
[158]Balletshofer BM, Rittig K, Rett K, Haring HU, Nawroth PP. Flow associated (endothelium dependent) vasodilation and TSH-levels in young normotensive and normoglycemic subjects. The Journal of Vascular Disease,2001,30 (2):97-100
[159]Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID, Lloyd JK, Deanfield JE. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. The Lancet,1992,340 (8828):1111-1115
[160]van Zaane B, Reuwer AQ, Buller HR, Kastelein JJ, Gerdes VE, Twickler MT. Hormones and cardiovascular disease:a shift in paradigm with clinical consequences? Seminars in Thrombosis and Hemostasis,2009,35 (5):478-487
[161]Cooke JP. The endothelium:a new target for therapy. Vascular Medicine,2000,5 (1):49-53
[162]Verma S, Buchanan MR, Anderson TJ. Endothelial function testing as a biomarker of vascular disease. Circulation,2003,108 (17):2054-2059
[163]Takase B, Uehata A, Akima T, Nagai T, Nishioka T, Hamabe A, Satomura K, Ohsuzu F, Kurita A. Endothelium-dependent flow-mediated vasodilation in coronary and brachial arteries in suspected coronary artery disease. The American Journal of Cardiology,1998,82 (12):1535-1539
[164]Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA, Deanfield J, Drexler H, Gerhard-Herman M, Herrington D, Vallance P, Vita J, Vogel R; International Brachial Artery Reactivity Task Force. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery:a report of the International Brachial Artery Reactivity Task Force. Journal of the American College of Cardiology,2002,39 (2):257-265
[165]Yeboah J, Crouse JR, Hsu FC, Burke GL, Herrington DM. Brachial flow-mediated dilation predicts incident cardiovascular events in older adults:The Cardiovascular Health Study. Circulation,2007,115 (18):2390-2397
[166]Yeboah J, Burke GL, Crouse JR, Herrington DM. Relationship between brachial flow-mediated dilation and carotid intima-media thickness in an elderly cohort. Atherosclerosis,2008,197 (2):840-845
[167]Matsushima Y, Takase B, Uehata A, Kawano H, Yano K, Ohsuzu F, Ishihara M, Kurita A. Comparative predictive and diagnostic value of flow2mediated vasodilation in the brachial artery and intima media thickness of the carotid artery for assessment of coronary artery severity. International Journal of Cardiology, 2007,117 (2):165-172
[168]Cabral MD, Teixeira PF, Silva NA, Morais FF, Soares DV, Salles E, Henriques JM, Leite SP, Montenegro CA, Vaisman M. Normal flow-mediated vasodilatation of the brachial artery and carotid artery intima-media thickness in subclinical hypothyroidism. Brazilian Journal of Medical and Biological Research,2009,42 (5): 426-432
[169]Xiang GD, He YS, Zhao LS, Hou J, Yue L, Xiang HJ. Impairment of endothelium-dependent arterial dilation in Hashimoto's thyroiditis patients with euthyroidism. Clinical Endocrinology,2006,64 (6): 698-702
[170]Papaioannou GI, Lagasse M, Mather JF, Thompson PD. Treating hypothyroidism improves endothelial function. Metabolism,2004,53 (3):278-279
[171]Cooper DS. Subclinical hypothyroidism. The New England Journal of Medicine,2001,345 (4):260-265
[172]滕卫平.开展亚临床甲状腺功能减退症的临床研究.中华内分泌代谢杂志,2004,20(2)：93-95
[173]胡玲,舒秉俊,邬国和,孙掌花,罗一湛,张建华,甘道龙,邱明琪.南昌地区亚临床甲状腺功能减退症的筛查分析.中华内分泌代谢杂志,2002,18(2)：127-129
[174]滕卫平.亚临床甲状腺功能减退症.国外医学内分泌学分册,2003,23(6)：370-372
[175]Munteis E, Cano JF, Flores JA, Martinez-Rodriguez JE, Miret M, Roquer J. Prevalence of autoimmune thyroid disorders in a Spanish multiple sclerosis cohort. European Journal of Neurology,2007,14 (9): 1048-1052
[176]Rivolta G, Cerutti R, Colombo R, Miano G, Dionisio P, Grossi E. Prevalence of subclinical hypothyroidism in a population living in the Milan metropolitan area. Journal of Endocrinological Investigation,1999,22 (9): 693-697
[177]Szabolcs I, Podoba J, Feldkamp J, Dohan O, Farkas I, Sajgo M, Takats KI, Goth M, Kovacs L, Kressinszky K, Hnilica P, Szilagyi G. Comparative screening for thyroid disorders in old age in areas of iodine deficiency, long-term iodine prophylaxis and abundant iodine intake. Clinical Endocrinology,1997,47 (1):87-92
[178]Roberts CG, Ladenson PW. Hypothyroidism. The Lancet,2004,363 (9411):793-803
[179]Huber G, Mitrache C, Meier C, Guglielmetti M, Huber P, Staub JJ. Long-term study of subclinical hypothyroidism:spontaneous course and predictor of manifest hypothyroidism. Schweizerische Medizinische Wochenschrift,1998,128 (48):2902-2905
[180]Singer P. Primary hypothyroidism due to other causes. In:Braverman LE, Utiger RD. Werner, Ingbar's the thyroid:a fundamental and clinical text. Philadelphia:Lippincott, Williams & Wilkins,2005,745-754
[181]Ayala AR, Danese MD, Ladenson PW. When to treat mild hypothyroidism. Endocrinology and Metabolism Clinics of North America,2000,29 (2):399-415
[182]Michael W, Tunbridge G, Vanderpump MP. Population screen for autoimmue thyroid disease. Endocrinology and Metabolism Clinics of North America,2000,29 (2):239-254
[183]史晓光,崇巍威,滕卫平,单忠艳,李玉姝,关海霞,滕晓春,佟雅洁,陈威,李智,满娜,滕笛.93例亚临床甲状腺功能减退症的随访研究.中华内分泌代谢杂志,2003,19(2)：86-88
[184]郑兵.甲状腺功能检测指标临床意义.实用内科杂志,2006,13(4)：547-548
[185]Huber G, Staub JJ, Meier C, Mitrache C, Guglielmetti M, Huber P, Braverman LE. Prospective study of the spontaneous course of subclinical hypothyroidism:prognostic value of thyrotropin, thyroid reserve, and thyroid antibodies. The Journal of Clinical Endocrinology and Metabolism,2002,87 (7):3221-3226
[186]Klein I, Ojamaa K. Thyroid hormone and the cardiovascular system. The New England Journal of Medicine,2001,344 (7):501-509
[187]Sawin CT, Geller A, Wolf PA, Belange AJ, Baker E, Bacharach P, Wilson P, Benjamin EJ, D'Agostino RB. Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. The New England Journal of Medicine,1994,331 (19):1249-1252
[188]Vanderpump MP, Tunbridge WM, French JM, Appleton D, Bates D, Clark F, Grimley Evans J, Rodgers H, Tunbridge F, Young ET. The development of ischemic heart disease in relation to autoimmune thyroid disease in a 20-year follow-up study of an English community. Thyroid,1996,6 (3):155-160
[189]Walsh JP, Bremner AP, Bulsara MK, O'Leary P, Leedman PJ, Feddema P, Michelangeli V. Subclinical thyroid dysfunction as a risk factor for cardiovascular disease. Archives of Internal Medicine,2005,165 (21): 2467-2472
[190]Sgarbi J, Matsumura L, Kasamatsu T, Ferreira S, Maciel R. Subclinical thyroid dysfunctions are independent risk factors for mortality in a 7.5-year follow-up:the Japanese-Brazilian thyroid study. European Journal of Endocrinology,2010,162 (3):569-577
[191]Dagre AG, Lekakis JP, Protogerou AD, Douridas GN, Papaioannou TG, Tryfonopoulos DJ, Papamichael CM, Alevizaki M. Abnormal endothelial function in female patients with hypothyroidism and borderline thyroid function. International Journal of Cardiology,2007,114 (3):332-338
[192]Razvi S, Ingoe L, Keeka G, Oates C, McMillan C, Weaver JU. The beneficial effect of L-thyroxine on cardiovascular risk factors, endothelial function, and quality of life in subclinical hypothyroidism: randomized, crossover trial. The Journal of Clinical Endocrinology and Metabolism,2007,92 (5): 1715-1723
[193]Raitakari OT, Celermajer DS. Flow-mediated dilatation. British Journal of Clinical Pharmacology,2000,50 (5):397-404
[194]Christ-Crain M, Meier C, Guglielmetti M, Huber PR, Riesen W,Staub JJ, Muller B. Elevated C-reactive protein and homocysteine values:cardiovascular risk factors in hypothyroidism? A cross-sectional and a double-blind, placebo-controlled trial. Atherosclerosis,2003,166 (2):379-386
[195]Kvetny J, Heldgaard PE, Bladbjerg EM, Gram J. Subclinical hypothyroidism is associated with a low-grade inflammation, increased triglyceride levels and predicts cardiovascular disease in males below 50 years. Clinical Endocrinology,2004,61 (2):232-238
[196]Tuzcu A, Bahceci M, Gokalp D, Tuzun Y, Gunes K. Subclinical hypothyroidism may be associated with elevated highsensitive c-reactive protein (low grade inflammation) and fasting hyperinsulinemia. Endocrine Journal,2005,52 (1):89-94
[197]Hueston WJ, King DE, Geesey ME. Serum biomarkers for cardiovascular inflammation in subclinical hypothyroidism. Clinical Endocrinology,2005,63 (5):582-587
[198]Luboshitzky R, Herer P. Cardiovascular risk factors in middle-aged women with subclinical hypothyroidism. Neuropean Endocrinology Letters,2004,25 (4):262-266
[199]Homoncik M, Gessl A, Ferlitsch A, Jilma B, Vierhapper H. Altered platelet plug formation in hyperthyroidism and hypothyroidism. The Journal of Clinical Endocrinology and Metabolism,2007,92 (8): 3006-3012
[200]Canturk Z, Cetinarslan B, Tarkun I, Canturk NZ, Ozden M, Duman C. Hemostatic system as a risk factor for cardiovascular disease in women with subclinical hypothyroidism. Thyroid,2003,13 (10):971-977
[201]Muller B, Taskiris DA, Roth CB, Guglielmetti M, Staub JJ, Marbet GA. Haemostatic profile in hypothyroidism as potential risk factor for vascular or thrombotic disease. European Journal of Clinical Investigation,2001,31 (2):131-137
[202]Folsom AR, Wu KK, Rasmussen M, Chambless LE, Aleksic N, Nieto FJ. Determinants of population changes in fibrinogen and factor Ⅶ over 6 years:the Atherosclerosis Risk in Communties (ARIC) Study. Arteriosclerosis, Thrombosis, and Vascular Biology,2000,20 (2):601-606
[203]Imaizumi M, Akahoshi M, Ichimaru S, Nakashima E, Hida A, Soda M, Usa T, Ashizawa K, Yokoyama N, Maeda R, Nagataki S, Eguchi K. Risk for ischemic heart disease and all-cause mortality in subclinical hypothyroidism. The Journal of Clinical Endocrinology and Metabolism,2004,89 (7):3365-3370
[204]Davis JD, Tremont G. Neuropsychiatric aspects of hypothyroidism and treatment reversibility. Minerva Endocrinologica,2007,32 (1):49-65
[205]Pollock MA, Sturrock A, Marshall K, Davidson KM, Kelly CJ, McMahon AD, McKaren EH. Thyroxine treatment in patients with symptoms of hypothyroidism but thyroid function tests within the reference range: randomised double blind placebo controlled crossover trial. British Medical Journal,2001,323 (7318): 891-895
[206]McDermott MT, Ridgway EC. Subclinical hypothyroidism is mild thyroid failure and should be treated. The Journal of Clinical Endocrinology and Metabolism,2001,86 (10):4585-4590
[207]Fatourechi V. Subclinical hypothyroidism:an update for primary care physicians. Mayo Clinic Proceedings, 2009,84(1):65-71
© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号 地址：北京市海淀区学院路29号 邮编：100083 电话：办公室：(+86 10)66554848；文献借阅、咨询服务、科技查新：66554700 |